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 The tautomerase superfamily is a group of structurally homologous proteins 
characterized by a β-α-β building block and a catalytic amino-terminal proline (Pro-1).  
The isomer specific hydrolytic dehalogenases, cis- and trans-3-chloroacrylic acid 
dehalogenase, (cis-CaaD and CaaD, respectively) are two superfamily members found in 
bacterial pathways for the catabolism of the nematocide 1,3-dichloropropene.  The 
enzyme-catalyzed addition of water produces two products, malonate semialdehyde and a 
halide ion.  Although the enzymes share a common catalytic tetrad, there are two notable 
differences:  two additional residues have been implicated in the cis-CaaD mechanism 
and mutagenesis analysis of the core catalytic residues suggests varying degrees of 
importance.  As part of an effort to understand the origin of these differences, a pre-
 
vii
steady state kinetic analysis of cis-CaaD was carried out.  For the analysis, an ion-
exchange method was developed for bromide quantification.  The analysis produced a 
five-step kinetic model in which substrate binding is followed by a conformational 
change.  Halide ion is released first in the rate limiting step followed by the release of 
malonate semialdehyde.  The stage is now set for a similar analysis of CaaD and the cis-
CaaD and CaaD mutants.  In the second part of the dissertation, (R)- and (S)-oxirane-2-
carboxylate were determined to be active-site-directed irreversible inhibitors of the cis-
CaaD homologue designated Cg10062 and found in Corynebacterium glutamicum.  
Kinetic analysis indicates that the (R)-enantiomer binds more tightly and is the more 
potent inhibitor.  Pro-1 is the sole site of modification by the (R)- and the (S)-enantiomer.  
The results are similar to those found for the irreversible inactivation of cis-CaaD by (R)-
oxirane-2-carboxylate with an important distinction: the alkylation of cis-CaaD is 
stereospecific.  Cg10062 exhibits a relaxed substrate specificity processing both the cis- 
and trans-3-chloroacrylic acid.  Delineation of the factors responsible for the 
stereoselective inactivation would provide a more complete picture of the substrate 
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Chapter 1:  Introduction 
 
1.1 An Overview of the Tautomerase Superfamily 
The tautomerase superfamily is a group of structurally homologous proteins that 
are characterized by a β−α−β building block and a catalytic amino-terminal proline (Pro-
1) (1-3). The signature β−α−β fold begins with Pro-1 at the start of a β-strand (β1), 
followed by an α-helix (α1) and a 310 helix, which precedes a second parallel β-strand 
(β2).  The fold ends with a β-hairpin near the C-terminus, which is important for 
oligomerization (Figure 1) (2).  The superfamily consists of five families represented by 
4-oxalocrotonate tautomerase (4-OT) (1), 5-(carboxymethyl)-2-hydroxymuconate 
isomerase (CHMI) (4), macrophage migration inhibitory factor (MIF) (5), cis-3-
chloroacrylic acid dehalogenase (cis-CaaD) (6), and malonate semialdehyde 
decarboxylase (MSAD) (7). The 4-OT family includes trans-3-chloroacrylic acid 
dehalogenase (CaaD) (8).  4-OT from Pseudomonas putida mt-2 and CHMI from 
Escherichia coli C function as tautomerases in degradation pathways for aromatic 
hydrocarbons and aromatic amino acids, respectively (4,9).  MIF is a pro-inflammatory 
cytokine, but also functions as a phenylpyruvate tautomerase (PPT) (5).  CaaD and cis-
CaaD precede MSAD in a degradation pathway for an isomeric mixture of 1,3-
dichloropropene, which is used as a nematocide (3).  CaaD, cis-CaaD, and MSAD are 
found in various gram-positive and gram-negative bacteria including P. pavonaceae 170 
and the coryneform bacterial strain FG41 (10). The characterized members in the 





Figure 1.1.  The characteristic β-α-β building block of the tautomerase superfamily.  The 
key structural elements are labeled and discussed in the text. 
 
In the tautomerase superfamily, Pro-1 can function as a general acid catalyst or a 
general base catalyst, depending on its protonation state (3).  4-Oxalocrotonate 
tautomerase (4-OT) and phenylpyruvate tautomerase (PPT) are two examples where Pro-
1 functions as a general base catalyst.  It functions as a general base because it has a pKa 
of 6.4 (4-OT) or 6.0 (PPT) so that Pro-1 exists largely in the unprotonated state at cellular 
pH (2,5).    
 4-OT is found in a bacterial pathway that degrades aromatic hydrocarbons (9).  It 
exists as a hexamer where each monomer consists of 62 amino acids (11-13).  It is 
proposed that 4-OT carries out a 1,3-allylic rearrangement where Pro-1 functions as a 
general base and abstracts a proton from C-3 of 2-oxo-4-hexenedioate (1, Scheme 1) to 
 
3
form the dienol intermediate, 2-hydroxymuconate (2, Scheme 1) (14-19).  This dienol 
intermediate then ketonizes to form the product, 2-keto-3-hexenedioate (3, Scheme 1). 
 














 Pro-1 also functions as a general base catalyst in the PPT-catalyzed reaction.  PPT  
converts phenylenolpyruvate (4, Scheme 2) to phenylpyruvate (5, Scheme 2) (5).  The 
physiological significance of this reaction is not known.  PPT is a trimer where each 






4 5  
 
 The discovery of the 1,3-dichloropropene catabolic pathway (Scheme 3) and the  
subsequent mechanistic and structural characterization of three enzymes in this pathway 
showed the versatility of Pro-1 (3).  In trans-3-chloroacrylic acid dehalogenase (CaaD), 
cis-3-chloroacrylic acid dehalogenase (cis-CaaD), and malonate semialdehyde 
 
4
decarboxylase (MSAD), Pro-1 functions as a general acid catalyst (3).  In these three 



























 Janssen and co-workers first cloned and expressed CaaD and proposed that the 
enzyme adds water to trans-3-chloroacrylic acid (8, Scheme 4) to form an unstable 
halohydrin intermediate (13) (20).  This halohydrin then collapses to release HCl and 
produce malonate semialdehyde (10, Scheme 4).  CaaD is a heterohexamer with 3 α-
subunits (75 amino acids each) and 3 β-subunits (70 amino acids each).  CaaD carries out 




















 cis-CaaD was been cloned and expressed by Whitman et al. and is highly specific 
for the cis-isomer of 3-chloroacrylic acid (9, Scheme 5) (6).  It was also proposed that 
 
5
cis-CaaD adds water to 9 to form an unstable halohydrin intermediate (13).  Like the 
proposed mechanism for CaaD, the halohydrin collapses to form HCl and malonate 
semialdehyde (10, Scheme 5).  Unlike CaaD, cis-CaaD is a trimer where each monomer 





















 MSAD has also been cloned and expressed by Whitman and co-workers (7).  It 
was determined to be a metal-ion independent decarboxylase.  MSAD catalyzes the 
decarboxylation of malonate semialdehyde (10, Scheme 6) where the cationic Pro-1 may 
polarize the 3-keto group of 10, and facilitate decarboxylation.  Subsequent ketonization 














+   CO2
 
 
 All three enzymes are found in a bacterial pathway that degrades 1,3-
dichloropropene (6, Scheme 3) (3).  The mixture of cis- and trans-1,3-dichloropropene is 
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the active ingredient in various nematocides marketed as Telone II and Shell D-D (10).  
These compounds are mixed into the soil to kill nematodes.  This compound is rapidly 
degraded in soil in part to this pathway.  In three enzyme-catalyzed steps, 1,3-
dichloropropene (6) is converted to the cis- and trans- isomers of 3-chloroacrylic acid 
(2,10).  CaaD and cis-CaaD then process the appropriate isomers of 3-chloroacrylic acid 
(8 and 9, respectively) to malonate semialdehyde (10).  MSAD processes malonate 
semialdehyde to acetaldehyde (11), which is likely channeled into the Krebs Cycle.   
 The mechanistic and structural diversity in the tautomerase superfamily raise 
question about how these enzymes evolved.  How enzymes evolve and how new 
enzymatic activities arise are two questions that have evoked much interest, discussion, 
and debate (21-24).  There is a considerable body of evidence suggesting that many 
enzymes evolve from a common ancestor by divergent evolution.  The growing number 
of superfamilies, with shared structural and functional features, provides strong support 
for divergent evolution (25-27).  The common explanation for divergent evolution 
involves gene duplication of the parent enzyme followed by limited random mutagenesis 
to produce a new enzymatic function.  The evolution of the new activity is driven by a 
selective advantage for the organism (e.g., frequently growth on alternative substrates).  
After the acquisition of a new activity, sequences likely diverge rapidly and markedly 
because there is little sequence identity among superfamily members (26a).   
  In the tautomerase superfamily, Nature has apparently fashioned new activities 
and structures by “stitching together” various combinations of the same simple structural 
unit, the β−α−β fold (1-3).  Thus far, there are superfamily members made of short 
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monomers (4-OT, CaaD) and those made of longer monomers (PPT, cis-CaaD, and 
MSAD) (1-3). The lessons learned from studies of these enzymes and how Nature 
stitched the scaffold together have enormous implications and tremendous potential.  If 
the principles used by Nature to create this diversity can be determined, it may be 
possible to mimic Nature’s strategy and create new proline-based biocatalysts with 
designed activities using the β-α-β scaffold (2,3).  
  In addition to the fact that the β−α−β motif has been used in different ways to 
generate diverse reaction types and structures, tautomerase superfamily members have 
three unique advantages that make them particularly attractive experimental vehicles for 
study.  The small monomer size, the absence of metal ions or coenzymes, and stability 
make them easily manipulated and amenable to study by a host of diverse techniques.  
These same features also make tautomerase superfamily members ideal candidates for the 
evolution of activities and the resulting insight into divergent evolution.  The new 
constructs are readily purified, their activities determined, and the mechanism and 
structures delineated by many different techniques.  These studies provide insight into the 
progenitors of these enzymes, suggest scenarios for the diversification of enzymatic 
function and mechanism within the tautomerase superfamily, and have implications for 
the evolution of metabolic pathways and enzymatic activities in general.   
1.2 trans-3-Chloroacrylic Acid Dehalogenase (CaaD) 
The genes (for the α- and β-subunits) for CaaD were initially cloned from P. 
pavonaceae strain 170, expressed, and the enzyme purified and characterized by Janssen 
et al (20).  CaaD is a heterohexamer, consisting of 3 α-subunits, (75 amino acid residues), 
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and 3 β-subunits, (70 amino acid residues).  Sequence analysis revealed similarities 
between the CaaD α-subunit and various 4-OT sequences (pairwise identities range from 
23-35%) and the CaaD β-subunit and the same 4-OT sequences (pairwise identities range 
from 16-25%).  This analysis implicated βPro-1 and αArg-11 as key catalytic residues, 
which was confirmed by site-directed mutagenesis (20).  Based on the 4-OT mechanism, 
it was initially proposed that Pro-1 functioned as a base to activate water and Arg-11 
interacted with the C-1 carboxylate group to facilitate the addition of water (20).  
With this information in hand, studies on CaaD were continued by Whitman et al.  
An efficient expression system for CaaD and a direct UV assay for monitoring activity 
(instead of the cumbersome colorimetric assay) were developed (28).  Product formation 
(i.e., 10 and the hydrate, Scheme 7) was verified by 1H NMR spectroscopy and CaaD’s 
behavior with three acetylene compounds (15, Scheme 8 and 19, 20, Scheme 9) was 
examined.  Compound 15, 2-oxo-3-pentynoate, is a potent active-site-directed 
irreversible inhibitor of 4-OT (17), and it was anticipated that if βPro-1 functioned as a 
base, it would be covalently modified by 15.  Instead, it was found that CaaD processed 
15 to acetopyruvate (18) quite efficiently (kcat = 0.7 s-1, Km = 110 mM, kcat/Km = 6.4 ×103 
M-1s-1) (28).  [CaaD processes 8 to 10 with a kcat = 3.8 s-1, a Km = 31 mM, and a kcat/Km = 
1.2 ×105 M-1s-1] (28). This was the first indication that there were differences between 
CaaD and 4-OT.  It was proposed that CaaD initiates the Michael addition of water to C-
4 of 15 to form 16 (Scheme 8) (28).  Protonation at C-3 of 16 leads to 17, which can, in 



































15 16 17 18  
 
The conversion of 15 to 18 suggested that CaaD might also add water to the 3-
halopropiolic acids (19 and 20, Scheme 9), transforming them into mechanism-based 
inhibitors.  Indeed, it was found that 19 and 20 are potent irreversible inhibitors of CaaD 
(28).  In one mechanism, hydration of these compounds results in the formation of an 
unstable enol, which ketonizes to an acyl halide (21, Scheme 9). Alternatively, the enol 
can directly expel halide to form a ketene.  Subsequent reaction with an active site 
nucleophile inactivates the enzyme.  Mass spectral analysis showed that the site of 
inactivation is βPro-1.  It should be noted that the initial hydration of 19 or 20 by CaaD 
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A crystal structure of CaaD inactivated by 20 was obtained (29).  The geometry of 
the complex identified a new catalytic residue, αGlu-52, and suggested that it activates 
water for nucleophilic attack while βPro-1 functions as a general acid catalyst (Scheme 
10).  The 3-carbonyl oxygen in 22 (Scheme 9) is likely derived from water so that the 
observed hydrogen bond distance between this oxygen and the oxygen of αGlu-52 
indicates that αGlu-52 is no longer ionized due to the abstraction of a proton from a 
water molecule (29).  The complex also identified αArg-8 as a second residue, which, 
along with αArg-11, binds to the carboxylate group of 8 (thus facilitating catalysis).  
Site-directed mutagenesis confirmed the importance of both αGlu-52 and αArg-8 to the 
mechanism (29). There was no detectable CaaD activity for the αE52Q mutant even after 
an extended (24 h) incubation period.  The activity observed after extended incubation 
times reflects slow catalysis, but should not be confused with a “resuscitation” of the 
enzyme.  The αR8A mutant has a small amount of activity over a 24-h incubation period.  
The βP1A mutant has no detectable activity within a 24-h incubation period but the 
αR11A mutant retains a small amount of activity.   Finally, an NMR titration of the 15N-
labeled CaaD showed that βPro-1 has a pKa of 9.2 (30).  Hence, CaaD became the first 
tautomerase superfamily member where Pro-1 functioned as an acid catalyst and not a 
base catalyst.  These studies led to the current working hypothesis for CaaD (Scheme 10).  
The mechanism can be extrapolated to provide a mechanism for the hydration of 15 
























































































1.3 cis-3-Chloroacrylic Acid Dehalogenase (cis-CaaD) 
The observation that both isomers of 1,3-dichloropropene (6, Scheme 3) were 
processed by various bacteria suggested that a cis-CaaD might be present in these 
bacteria.  Indeed a cis-CaaD was isolated from coryneform bacterium strain FG41 in 
1992 (10).  The enzyme was purified and a large fragment sequenced.  It was reportedly a 
dimer or trimer consisting of 16.2 kDa subunits (10b).  A comparison of its N-terminal 
amino acid sequence (48 amino acids) with the α- and β- subunits of CaaD revealed little 
sequence identity, but the amino-terminal proline was conserved. 
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With this information in hand, the gene for cis-CaaD from coryneform bacterium 
strain FG41 was cloned, expressed, and subsequently the protein product was purified 
and characterized (6).  The enzyme is a trimer where each monomer consists of 149 
amino acids.  Like CaaD, it is highly isomer specific.  Sequence alignment and structural 
analysis implicated Pro-1, Arg-70, Arg-73, and Glu-114 as active-site residues (6).  Site-
directed mutagenesis experiments confirmed their importance.  Once again, the acetylene 
compounds, (15, Scheme 8 and 19 and 20, Scheme 9) were processed by cis-CaaD to 
products consistent with an enzyme-catalyzed hydration reaction previously established 
for CaaD (6).  Hydration of 15 afforded 18 (although not as efficiently as CaaD) while 
the 3-halopropiolates (e.g., 19 and 20) are irreversible inhibitors that covalently modify 
Pro-1.  In addition, pH profiles suggested that an acid catalyst (pKa of 9.3) is required for 
activity (6).  Although the pKa of Pro-1 has not yet been determined by direct NMR 
titration, the pKa is likely that of Pro-1.  These results suggested an initial mechanism for 
cis-CaaD that parallels that of CaaD (Scheme 10, replacing αGlu-52 with Glu-114, 
αArg-8 with Arg-70, αArg-11 with Arg-73, and βPro-1 with Pro-1) (6).     
Mutagenesis results and inhibition studies uncovered differences between the 
CaaD and cis-CaaD mechanisms (with potential evolutionary implications).  The first 
difference emerged from a comparison of mutagenesis results (6).  The αE52Q mutant of 
CaaD is more inactive than the E114Q mutant of cis-CaaD.  The E114Q-cis-CaaD has 
diminished activity (~10-fold decrease in kcat/Km), but clearly shows activity without 
resorting to a 24-h incubation period.  This observation suggested that water activation is 
more complex (i.e., more residues involved) in cis-CaaD than it is in CaaD.  The second 
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difference came from inhibition studies using (R)- and (S)-oxriane-2-carboxylate (23, 
Scheme 12) (31).  Only cis-CaaD is inactivated (irreversibly) and only by the R-
enantiomer.  It was also found that Pro-1, Arg-70, and Arg-73 are required for covalent 
modification (i.e., the P1A, R70A, and R73A mutants are not modified), but Glu-114 is 
not required (i.e., the E114Q mutant is covalently modified).  Mass spectral analysis 
showed (once again) that Pro-1 is the site of covalent modification.   
The crystal structures of native cis-CaaD and cis-CaaD inactivated by (R)-23 (32) 
were solved.  The observations gleaned from these two structures have four major 
implications.  First, the native structure identified Tyr-103 and His-28 as additional 
catalytic residues. The structures suggest that Tyr-103 assists Glu-114 in the activation of 
water and His-28 assists Arg-70/Arg-73 in the activation of substrate through an 
interaction with the carboxylate group.  These observations and mutant analysis suggest 
that water activation is more important to catalysis in CaaD whereas substrate activation 
is more important in cis-CaaD.  Second, the inactivated structure confirmed the nature of 
the covalent adduct (e.g., 24, Scheme 12), established that C3 of 23 is the site of 
nucleophilic attack by Pro-1 (as the neutral form, which, under the pH conditions of the 
inactivation experiments, is present in ~1%), and implicated His-28 as a major 
determinant in positioning (R)-23 for alkylation of Pro-1 and subsequent inactivation. 
Third, His-28 and Tyr-103 appear to be two determinants of the cis-CaaD substrate 
specificity.  Finally, the results are consistent with the proposal that cis-CaaD and CaaD 
form two separate lineages that followed the independent duplication of a 4-OT-like 













The crystal structure of the inactivated cis-CaaD [by (R)-23] and mutant analysis 
suggest a mechanism for inactivation, a structural basis for the stereospecificity of the 
reaction [i.e., only the (R)-enantiomer inactivates cis-CaaD], and a rationale for the 
observation that CaaD is not inactivated by either enantiomer of 23 (32).  The 
interactions in the crystal structure suggest that Arg-73 and His-28 are involved in 
binding the carboxylate of (R)-23 (Scheme 13A) and that Arg-70 may facilitate ring 
opening by direct interaction with the epoxide oxygen or by placing a water molecule in 
position to interact with the epoxide oxygen (32).  If (S)-23 binds with similar 
interactions between the carboxylate group and Arg-73 and His-28 (Scheme 13B), the C3 
carbon is directed away from Pro-1 and towards Arg-70.  This binding mode precludes 
alkylation.  The absence of His-28 in CaaD suggests that the carboxylate group of 23 
might now interact with both arginines (in CaaD, αArg-8 and αArg-11).  This interaction 





























With regard to substrate specificity, a comparison of the cis-CaaD and CaaD 
structures offers an explanation (29,32).  In cis-CaaD, the carboxylate group of 9 is 
bound by the His-28/Arg-70/Arg-73 cluster, such that the substrate is directed towards 
the enzyme’s surface (32).  In CaaD, the carboxylate group of the substrate is bound by 
the αArg-8/αArg-11 pair, with the remainder of the substrate projecting deeper into the 
active site (29).  The substrate-binding pockets fit the shape of their respective substrates, 
that is, the pocket of cis-CaaD is more U-shaped, whereas the pocket of CaaD is more 
elongated.  One of the residues responsible for this shape difference is Tyr-103 (αVal-41 
in CaaD).  In CaaD, αVal-41 creates a hydrophobic region allowing the 3-chloro moiety 
of 8 to bind between αPhe-39 and αPhe-50.  The presence of the larger Tyr-103 residue 
in cis-CaaD effectively blocks the binding of the 3-chloro group of 8.  Instead, a 
hydrophobic pocket formed by the side chains of Thr-34, Leu-38 and Leu-119 could 
favor the binding of the 3-chloro moiety of 9.  Thus, His-28 and Tyr-103 might be two 





1.4   Malonate Semialdehyde Decarboxylase (MSAD) 
Janssen et al. reported that the genes for the CaaD α- and β-subunits are found in 
a cluster (in P. pavonaceae 170) that includes two additional open reading frames located 
immediately downstream (20). One, orf130, was hypothesized to function as a malonate 
semialdehyde decarboxylase (MSAD) (20).  The other open reading frame likely encodes 
a dehydrogenase, based on sequence analysis.  Hence, the orf130 gene was cloned and 
expressed, and the protein product was purified and characterized (7).  MSAD is a trimer 
where each subunit consists of 129 amino acids. The enzyme was shown to carry out a 
metal-ion independent decarboxylation reaction (using 10 in Scheme 6, and generating 11 
and the hydrate).  Sequence analysis uncovered a relationship with the tautomerase 
superfamily (but representing yet another new family) and implicated Pro-1 and Arg-75 
as potential active site residues. Site-directed mutagenesis confirmed the importance of 
these residues for activity.  
It was proposed that MSAD could proceed through a Schiff base mechanism or 
one in which a cationic Pro-1 polarized the 3-carbonyl group of 10 (33).  A distinguishing 
feature between mechanisms is the ionization state of Pro-1.  Accordingly, the behavior 
of MSAD with 15 (Scheme 8) was determined and the pKa of Pro-1was measured by 
direct 15N NMR titration (using uniformly 15N-labeled enzyme) (33).  
MSAD converts 15 to 18 (Scheme 8), a process which also required Pro-1 and 
Arg-75.  Hence, MSAD is a decarboxylase with a promiscuous hydratase activity.  In 
addition, the pKa of Pro-1 was determined to be ~9.2 by NMR titration (33).  These 
observations argued against a Schiff base mechanism and in favor of the mechanism 
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where Pro-1 polarizes the carbonyl oxygen of substrate by hydrogen bonding and/or an 
electrostatic interaction (Scheme 14).  Arg-75 is postulated to position the carboxylate 
group in a favorable orientation for decarboxylation.  In view of the promiscuous 
hydratase activity (uncovered by the conversion of 15 to 18), MSAD was incubated with 
the potential mechanism-based inhibitors, 19 and 20 (Scheme 9) (34).  Analysis showed 
that both compounds inactivated MSAD and, once again, Pro-1 was the site of 
modification (34). It is presumed that the initial hydration of 19 or 20 by MSAD removes 
























Subsequently, crystal structures of native MSAD, the P1A mutant, and MSAD 
inactivated by 19 were determined (35). The structures confirm that MSAD is metal-ion 
independent (i.e., there is no metal ion in the active despite the high concentrations in 
crystallization buffers).  The P1A mutant structure is nearly identical to that of the native 
structure (except for the mutation) suggesting that the loss of activity associated with this 
mutant does not result from a structural defect.  In the structure of MSAD inactivated by 
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19, the positioning of the 3-oxopropanoate adduct (22, Scheme 9) implicated Asp-37 and 
Arg-73 as two additional catalytic residues in the decarboxylation and hydration 
mechanisms. The importance of these residues to both mechanisms was confirmed by 
site-directed mutagenesis.  These observations and all of the preceding mechanistic work 
led to the current working hypotheses for the hydration and decarboxylation mechanisms 
(Schemes 11 and 14).   
The decarboxylation mechanism is summarized in Scheme 14.  Asp-37 may play 
an indirect role in the decarboxylase activity as it may be partially responsible for the 
observed pKa of Pro-1 (~9.2) (35).  This putative role for Asp-37 is based on its observed 
participation in the hydrogen bond network.  The proposed mechanism for the hydration 
of 15 parallels that of CaaD (Scheme 11) where Asp-37 replaces αGlu-52, Arg-73/Arg-
75 replace αArg-8/αArg-11, and Pro-1 replaces βPro-1.  Asp-37 could activate a water 
molecule for nucleophilic attack at C-4 of 15 to initiate the Michael addition of water.  
Arg-73 and Arg-75 could polarize the carbonyl oxygen and assist in binding of the 
carboxylate group.  Pro-1 is an obvious candidate to provide a proton at C-3 to complete 
the Michael addition of water.  Ketonization of 17 to 18 could be enzyme-catalyzed or a 
non-enzymatic process. 
1.5 Evolution of trans-3-Chloroacrylic Acid Dehalogenase, cis-3-Chloroacrylic 
Acid Dehalogenase, and Malonate Semialdehyde Decarboxylase  
 
Various scenarios have been proposed for the evolution of CaaD, cis-CaaD, and 
MSAD.  For CaaD and cis-CaaD, the conservation of the β−α−β fold and the key 
functional groups [Pro-1, αArg8/αArg11, Arg-70/Arg-73, and αGlu-52/Glu-114] 
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indicate that the two enzymes are related by divergent evolution from a common ancestor 
(32).  The different oligomer structures (heterohexamer vs trimer) and low sequence 
identity (<20%) indicate that CaaD and cis-CaaD diverged some time ago.  The presence 
of His-28 and Tyr-103 in the cis-CaaD active site (and the low sequence identity) invoke 
a scenario in which cis-CaaD evolved from an independent gene duplication event of a 
small β−α−β gene (e.g., a 4-OT-like gene) followed by gene fusion (32).  CaaD also 
might have evolved from gene duplication of a small β−α−β gene, but the two genes co-
evolved to form the two subunits of CaaD. 
  The similarities between CaaD/cis-CaaD and MSAD and the fact that they 
catalyze successive reactions in the 1,3-dichloropropene catabolic pathway suggest that 
they may have also evolved by “retrograde evolution” in that they diverged from an 
ancestral enzyme that catalyzed both reactions (21,35).  For CaaD and MSAD, the two 
enzymes are structurally homologous and key catalytic residues (Pro-1 and the two 
arginines) are positionally conserved (35).  These observations are significant in view of 
the functional similarities between the enzymes.  Both function as hydratases, converting 
15 to 18, and both use Pro-1 (with a pKa of ~9.2) and conserved arginines to catalyze this 
reaction as well as their physiological reactions (35).  Finally, as a result of the hydration 
reaction, the 3-halopropiolates are converted to reactive species that alkylate and 
inactivate both enzymes.   
In one scenario, the ancestral enzyme may have functioned primarily as a 
hydratase because the hydration of 8, an α,β-unsaturated acid, is the chemically more 
difficult reaction.  A random encounter of 10 with the cationic Pro-1 could result in 
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decarboxylation and make this ancestral hydratase an accidental decarboxylase.  In this 
scenario, gene duplication (and gene fusion) gave rise to separate enzymes that retained 
the components for the hydration reaction along with the rudimentary decarboxylase 
activity.  Enhancement of the accidental decarboxylase activity could result from a 
limited number of mutations that increased the probability of encounter and optimized the 
position of 11 with respect to the cationic Pro-1 and introduced additional catalytic 
elements to facilitate decarboxylation.  The hydratase activity of MSAD is then a 
remnant.   
1.6 Cg10062, a cis-Chloroacrylc Acid Dehalogenase Homologue, from 
Corynebacterium glutamicum 
 
In the characterization of the cis-CaaD family, a 149-amino acid cis-CaaD 
homologue from C. glutamicum, designated Cg10062 was identified (6). The 
physiological function of Cg10062, (which will be called CgX hereafter), is unknown and 
the gene has no apparent genomic context.  The protein shares 34% sequence identity 
(and 53% similarity) with cis-CaaD and the residues implicated as critical ones for cis-
CaaD activity are present (Pro-1, His-28, Arg-70, Arg-73, Tyr-103, Glu-114) (6,32).  The 
gene has been cloned, the protein overexpressed, purified, and subjected to kinetic and 
mechanistic characterization.  There is 1H NMR spectroscopic evidence showing that 
CgX has cis-CaaD and CaaD activity.  The cis-CaaD activity is greater than that of CaaD.  
Like CaaD, cis-CaaD, and MSAD, the protein is inactivated by 19 and 20, and converts 
15 to 18.    
The mechanism of CgX is intriguing for three major reasons. First, it could serve 
as a future template for the evolution of cis-CaaD and CaaD, and recapitulate the 
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emergence of isomer specificity.  Second, CgX has the six core catalytic residues found 
in cis-CaaD but is a very poor cis-CaaD.  It would be interesting to determine the factors 
that account for the decreased activity.  Third, an analysis of the structural factors 
responsible for CgX’s relaxed specificity could provide a more complete understanding 
of the substrate specificity of CaaD and cis-CaaD.  For these reasons, studies of CgX 
were pursued in this dissertation.   
1.7 Summary 
  The preceding mechanistic, mutagenesis, and structural studies of CaaD, cis-
CaaD, and MSAD established minimal mechanisms for each enzyme (Schemes 10 and 
14).  These studies have also uncovered intriguing similarities, fascinating differences, 
and tantalizing evolutionary histories for the three enzymes.  However, many mechanistic 
and evolutionary questions remain unanswered.  For example, in CaaD, the actual 
interactions of the arginine pair (αArg-8/αArg-11 in Scheme 10) with substrate are not 
known.  Moreover, it seems unusual that two arginines are necessary for substrate 
activation (i.e., polarization of the carboxylate group of 8).  The structural basis for the 
pKa of Pro-1 is unknown as well as the observation that Pro-1 is so critical for activity.  
These same questions apply to cis-CaaD with some differences.  It is interesting that the 
cis-CaaD reaction requires additional groups for water activation (i.e., Tyr-103 and Glu-
114) and substrate activation (an arginine pair, Arg-70/Arg-73, and His-28).  It is also 
intriguing that water activation appears to be more important in CaaD and substrate 
activation may be more important for cis-CaaD.  The structural basis for the isomer 
specificity is also not known.   
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 For both enzymes, it is not known if there is a halohydrin (e.g., 13, Scheme 10) or an 
enol (e.g., 14) intermediate, and whether either of these putative intermediates undergoes 
chemical or enzymatic decay (and what groups are involved) to yield product, 10.  It is 
also not known if CaaD and cis-CaaD are physiological dehalogenases or “accidental” 
dehalogenases.  As a physiological dehalogenases, one anticipates that the steps after 
water addition are enzyme-catalyzed and that there may be a halide-binding pocket.  As a 
physiological hydratase (of an unknown substrate), CaaD may just catalyze the addition 
of water to various α,β-unsaturated acids (including 8 and 9).  Addition of water to 8 or 9 
results in 13, which could undergo rapid chemical decay.   
 This dissertation focused on the feasibility and execution of kinetic studies of cis-
CaaD and CaaD, and inactivation studies of CgX.  First, methodology was developed to 
carry out a pre-steady-state kinetic analysis of CaaD, cis-CaaD, and various mutants.  
Second, the methodology was used in stopped flow and rapid chemical quench 
experiments on cis-CaaD.  These experiments resulted in a kinetic mechanism for cis-
CaaD.  Stopped flow experiments were also carried out on the αF39W-CaaD mutant 
(introducing a fluorophore) and selected mutants of cis-CaaD.  The completion and 
comparison of the results may show whether the observed macroscopic properties 
(substrate activation vs water activation, for example) occur due to differences in kinetic 
mechanisms, microscopic rate constants, or a combination.   The results may also be 
more informative about how a mutation affects a particular step in the mechanism and the 
extent to which that mutation impacts the particular step.  Finally, the behavior of CgX 
with the enantiomeric epoxides [e.g., (R)- and (S)-23, Scheme 12] was examined.   
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Although the (R)-enantiomer is more potent, both enantiomers inactivate CgX with Pro-1 
being the site of modification.  The results set the stage for crystallographic analysis, 
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2.1 Introduction   
  The catabolism of 1,3-dichloropropene (1, Scheme 1) in Pseudomonas 
pavonaceae 170 and coryneform bacterium strain FG41 involves the hydrolytic 
dehalogenation of cis- and trans-3-chloroacrylic acid (2 and 3, respectively) resulting in 
malonate semialdehyde (4) (1,2).  Subsequently, the β-keto acid undergoes an enzyme-
catalyzed decarboxylation to yield acetaldehyde (5), which is presumably funneled into 
the Krebs cycle (1,2).  Each isomer of 3-chloroacrylic acid is converted to 4 by a separate 
dehalogenase known as cis- or trans-3-chloroacrylic acid dehalogenase, (cis-CaaD and 
CaaD, respectively) (2).  Both enzymes are members of the tautomerase superfamily, 
although from different families, and share a common β−α−β  building block and a 
























  In the current working hypotheses for the CaaD and cis-CaaD mechanisms, the 
same four active site residues are key components (Scheme 2).  In CaaD, a 
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heterohexamer made up of 3 α-subunits and 3 β-subunits, αGlu-52 abstracts hydrogen 
from water for addition to C-3 of 3 and a pair of arginines (αArg-8 and αArg-11) 
interacts with the C-1 carboxylate group.  This interaction binds and polarizes the 
substrate to facilitate attack at C-3.  The addition of water to the double bond of 3 is 
completed by the delivery of a proton to C-2 by βPro-1, functioning as a general acid 
catalyst (5-8).  A similar sequence of events is proposed for the trimeric cis-CaaD where 


















































   
  In the proposed catalytic mechanism, the polarization of 3 and addition of water 
generate an enediolate species (6, Scheme 2) (11).  Subsequent ketonization by route A 
results in an unstable chlorohydrin intermediate, which can undergo chemical or 
enzymatic decay to afford 4 and HCl.  Alternatively, the enediolate species can expel the 
chloride ion (i.e., an α,β-elimination), as shown in route B, to form the enol intermediate, 
8.  Ketonization of 8 then produces 4.  Recent experiments showing that the ketonization 
of phenylenolpyruvate to phenylpyruvate is kinetically competent in the overall CaaD 
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reaction is consistent with route B, but not conclusive (12).  The reaction is also 
stereoselective when carried out in D2O (12).   
  In addition to the different quaternary structures (i.e., heterohexamer vs trimer), 
there are mechanistic distinctions between the two enzymes (11).  Crystallographic 
studies identified two additional residues, His-28 and Tyr-103, that assist catalysis in cis-
CaaD (11).  The positions of these residues in the structures suggested that Tyr-103 
assists Glu-114 in the activation of water and His-28 assists the two arginines in the 
binding and polarization of substrate.  Moreover, mutagenesis analysis suggests that 
water activation is more critical for the CaaD mechanism whereas substrate activation 
plays a more significant role in the cis-CaaD mechanism (11).  For example, replacing 
αGlu-52 of CaaD with a glutamine renders the enzyme totally inactive, but the analogous 
mutant in cis-CaaD only diminishes activity (7, 9).  Likewise, replacing Arg-70 or Arg-
73 with an alanine completely eliminates cis-CaaD activity (11), but the corresponding 
mutations in CaaD do not (7).  The amino-terminal proline is critical for both activities 
(5, 6, 9).   
  Although mutant analysis has provided some measure of the relative importance 
of key residues in these two enzymes, it has not generally been highly informative.  Most 
mutants show very little or no measurable activity and long incubation periods are 
necessary to gauge the importance of a residue in the mechanism.  For these reasons and 
the fact that many details of catalysis are not well understood, a pre-steady state kinetic 
analysis of both enzyme-catalyzed reactions and their mutants is being pursued.  Similar 
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studies on other dehalogenases have been enlightening, identifying the rate limiting steps 
and uncovering details about halide release (13).   
It was not clear at the outset how feasible these experiments would be.  The 
reaction is functionally irreversible and one product, malonate semialdehyde (4), is in 
rapid equilibrium with the hydrate, and undergoes a facile chemical decarboxylation to 
form acetaldehyde, which is also in equilibrium with the hydrate.  Nonetheless, for cis-
CaaD, conditions have now been identified to carry out stopped-flow fluorescence and 
chemical quench experiments and an assay developed to quantify bromide ion.   Thus far, 
these studies led to a five-step kinetic model for the wild type enzyme.  The mechanism 
involves substrate binding, conformational change, formation of product, and product 
release in two steps: release of bromide followed by the release of malonate 
semialdehyde. Global fitting of the data to this model provided kinetic constants for each 
of these steps.  In addition, stopped flow experiments have been carried out on the six 
mutants of cis-CaaD and their ground-state binding constants derived.  A rapid chemical 
quench experiment was also done on the E114Q mutant of cis-CaaD.  Like wild type, a 
burst of product formation is observed, suggesting that there is a rate limiting step after a 
chemical step.   
2.2  Materials and Methods 
  Materials.  Chemicals, biochemicals, buffers, and solvents were purchased from 
Sigma- Aldrich Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Pittsburgh, PA), 
Fluka Chemical Corp. (Milwaukee, WI), or EM Science (Cincinnati, OH).  Reagents 
used in the ion chromatography and rapid quench experiments were at least 99.99% pure 
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or higher.  Enzymes and reagents used for molecular biology procedures were obtained 
from New England Biolabs, Inc. (Ipswich, MA).  The PolyVial 0.5 mL vials, filter caps, 
and 0.5 mL automated sampler cassettes were purchased from Dionex Corporation 
(Sunnyvale, CA).  The Microcon centrifugal filter devices, 3,000 MWCO, the Amicon 
stirred cells, and the YM3 and YM10 ultrafiltration membranes were purchased from 
Millipore Corporation (Billerica, MA). Pre-packed PD-10 Sephadex G-25 columns were 
purchased from Biosciences AB (Uppsala, Sweden). 
 Bacterial Strains, Plasmids, and Growth Conditions.  E. coli BL21-Gold(DE3) cells 
were purchased from Stratagene (La Jolla, CA).  The construction of plasmids for the 
expression of cis-CaaD is described elsewhere.  The sources for the components of Luria-
Bertani (LB) media are reported elsewhere (6, 14). 
 General Methods. Mass spectral data were obtained on an LCQ electrospray ion-trap 
mass spectrometer (ThermoFinnigan, San Jose, CA) in the Analytical Instrumentation 
Facility Core in the College of Pharmacy at the University of Texas at Austin (6).  
Steady-state kinetic parameters were obtained at 24 °C on an Agilent 8453 diode-array 
spectrophotometer.  Nonlinear regression data analysis was performed using the program 
Grafit (Erithacus Software Ltd., Staines, U.K.) obtained from Sigma-Aldrich.  The pre-
steady state kinetic data were fit and simulated using KinTek Global Kinetic Explorer 
(Austin, TX).  Protein concentrations were determined by the method of Waddell (15).  
Proteins were analyzed by SDS-PAGE under denaturing conditions on gels containing 
15% polyacrylamide (16).  
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  Ion Chromatography. The dehalogenation of cis-3-bromoacrylate in chemical 
quench experiments was quantified by measuring the bromide ion concentration by ion 
chromatography (IC).  The Dionex ion chromatograph (Dionex Corp) (equivalent to the 
3500 model), consisted of a LC25 chromatography oven, an EG50 eluent generator, a 
GS50 gradient pump, an ED50 electrochemical detector, and an AS40 autosampler.  The 
instrument was equipped with an AG12A pre-column (4 × 40 mm), an IonPac AS12A 
column (4 × 200 mm) and an anion self-regenerating suppressor (ASRS) ULTRA II, 4 
mm suppressor.  Anion detection was performed by electrical conductivity.  A solution of 
2.7 mM Na2CO3/0.3 mM NaHCO3 (pH 9.6) was used as the eluent at a flow rate of 1.5 
mL/min.   
  Composition of SOB and SOC Media.  The SOB medium was made by mixing 
tryptone (4 g) and yeast extract (1 g) in 100 mL of deionized water (14).  The mixture 
was then autoclaved for 45 min and stored in a sealed glass bottle at 22 °C until ready to 
use.  The SOC medium (10 mL) was made by mixing 4.7 mL of deionized water with 
SOB medium (5 mL).  To this mixture, MgSO4 (0.1 mL of a 1 mg/mL stock solution), 
NaCl/KCl (0.1 mL of a 1 mg/mL stock solution), and glucose (0.1 mL of a 1 mg/mL 
stock solution) were added.  The solution was mixed at 22 °C and used immediately after 
being made.   
2.2.1 Transformation, Expression and Purification of cis-CaaD  
Transformation of Expression Cells for cis-CaaD.  E. coli BL21-Gold(DE3) 
competent cells were thawed and stored on ice.  Competent cells (~100 µL) were pipetted 
into a pre-chilled 15-mL Falcon 2059 tube along with pCC5 [also known as pET(cis-
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CaaD#5)] (~50 ng). The construction of pCC5 is described elsewhere and encodes the 
gene sequence for cis-CaaD (9). The reaction mixture was gently incubated on ice for 30 
min.  During this time, 900 µL of SOC medium was preheated in a water bath to 42 °C.  
The reaction mixture was heat-pulsed for 20 s in a water bath at 42 °C and then incubated 
on ice.  After 2 min, the 900-µL aliquot of SOC medium was added to the reaction 
mixture.  The cells were incubated at 37 °C for 1 h in an environmental shaker at 225 
rpm.  The cells were then concentrated by centrifugation (500 rpm for 5 min), and a 600-
µL portion of the supernatant was removed.  The cells were resuspended in the remaining 
supernatant.  A portion of the resulting transformation reaction mixture (200 µL) was 
plated, using a sterile spreader, onto a single LB/Ap (50 µg/mL) plate.  The plate was 
then incubated overnight (~ 16 h) at 37 °C.   
Expression and Purification of cis-CaaD.  Wild-type cis-CaaD was produced in E. 
coli BL21-Gold(DE3) cells using the T7 expression system (9).  The freshly transformed 
cells, with the plasmid containing the cis-CaaD gene, were collected from a plate and 
used to inoculate two 2-liter flasks containing 1L of LB/Ap (100 mg/L).  After overnight 
growth at 30 °C in an environmental shaker at 225 rpm, cells were harvested by 
centrifugation (15 min at 7,000 rpm) and stored at -20 °C until further use.  Typically, 1 
L of culture yields 5 g of cells. 
Cells (10 g) were thawed and suspended in 10 mL of 10 mM Tris-SO4 buffer, pH 
8.0, and placed on ice (9).  Cells were disrupted, while stirring on ice, by sonication at 60 
W output (using a W385 sonicator of Heat Systems-Ultrasonics, Inc.) for ten 2-min 
intervals using 5-s pulses with a cycle time of 50%.  After each 2-min interval, the cells 
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were allowed to sit for 5 min.  DNase (10 µL of a 10 Units/µL solution) and RNase (10 
µL of a 500 µg/mL solution) were added to the solution and allowed to stir on ice for 1 h.  
The lysed cells were then centrifuged at 17,000 rpm for 45 min. The supernatant was 
retained and centrifuged at 60,000 rpm for 1 h.  
 Subsequently, the supernatant was filtered through a 0.2 µm-pore diameter filter 
and applied to a TSKgel DEAE-5PW anion-exchange column (150 × 21.5 mm) which 
had been previously equilibrated with 10 mM Tris-SO4 buffer, pH 8.0 (9). The protein 
was eluted with a linear gradient (0-0.5 M Na2SO4) at a flow rate of 5 mL/min over a 90 
min period.  Fractions were collected at 1.75 min intervals (8.75 mL).  Fractions (#5-13) 
with the highest purity (as determined by SDS-PAGE) were pooled and concentrated to 
~20 mL using an Amicon stirred cell equipped with a YM10 (10,000 MW cutoff) 
ultrafiltration membrane.   
Solid (NH4)2SO4 was added to the concentrate to make a final concentration of 
1.0 M and the resulting solution was stirred for 1 h at 4 °C (9).  The solution was then 
centrifuged at 11,000 rpm for 15 min and the supernatant was filtered through a 0.2 µm-
pore diameter filter and applied to a TSKgel Phenyl-5PW column (150 × 21.5 mm), 
which had been previously equilibrated with 10 mM Tris-SO4 buffer, pH 8.0, containing 
1.0 M (NH4)2SO4. The protein was eluted using a decreasing linear gradient [1.0-0 M 
(NH4)2SO4] at a flow rate of 5 mL/min.  Fractions were collected at 1.75 min intervals 
(8.75 mL) during the 90 min program.  Fractions (#10-12) with the highest purity (as 
determined by SDS-PAGE) were pooled and concentrated to ~6 mL using an Amicon 
stirred cell equipped with a YM10 (10,000 MW cutoff) ultrafiltration membrane and 
 
37
stored at 4 °C.  This purification resulted in ~100 mg of 95% pure protein as assessed by 
ESI mass spectroscopy and SDS-PAGE. The observed monomer mass for cis-CaaD was 
16,622 Da.  
2.2.2 Steady-State Kinetic Parameters for cis-CaaD  
Steady-State Kinetic Parameters for cis-CaaD..  The steady-state parameters for 
cis-CaaD was measured using cis-3-chloro- or cis-3-bromoacrylic acid.  The assays were 
carried out at 22 °C in 20 mM Na2HPO4 buffer, pH 9.0, or in 20 mM NaHCO3-NaOH 
buffer, pH 9.0, as indicated.  A 25 mL solution of enzyme (2 µM based on monomer 
mass) was made up in each buffer and allowed to equilibrate at 22 °C for 1 h.  The assay 
was initiated by the addition of cis-3-chloro or cis-3-bromoacrylic acid (10-700 µM), 
which were obtained from a 10 mM or 50 mM stock solutions (in 100 mM Na2HPO4 
buffer, pH 9.0). The addition of cis-3-chloro- or cis-3-bromoacrylic acid to the 100 mM 
sodium phosphate buffer adjusted the pH of the stock solution from 9.0 to 7.3. The 10 
mM stock solution was made by diluting an aliquot of the 50 mM stock solution into 100 
mM NaH2PO4 buffer, pH 7.3.  For wild type enzyme, the decrease in absorbance at 224 
nm, corresponding to the hydration of cis-3-chloroacrylate (ε = 2900 M-1 cm-1) (9) or cis-
3-bromoacrylate (ε = 3600 M-1 cm-1) (9), was monitored over a 40s time period, 
recording readings every 1.5 s. The two mutants were monitored over a 60s time period.  
The rates of substrate depletion over the first 20 s were then plotted versus the 
corresponding concentrations.  The hyperbolic curve was fit to the Michaelis-Menten 
equation by nonlinear regression analysis, provided in the Grafit program (Erithacus 
Software Ltd., Horley U.K.), to determine the values of kcat and Km.   
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2.2.3 Inhibition of cis-CaaD by Halide Ion 
Inhibition of cis-CaaD by Halide Ion.  The inhibition of cis-CaaD by halide ion 
was carried out using cis-CaaD (2 µM based on monomer mass) in 50 mL of 20 mM 
NaHCO3-NaOH buffer, pH 9.0.  The enzyme solution was made up and allowed to sit at 
room temperature for 1 h before two 15-mL aliquots were removed and placed in 
separate 50-mL Falcon tubes.  Two portions of KBr (17.85 mg and 4.46 mg) were added 
to the individual tubes to give final concentrations of 2.5 mM and 10 mM bromide, 
respectively.  Steady-state kinetic parameters were then measured in the presence of cis-
3-bromoacrylic acid (10–800 µM).  The reactions were initiated by the addition of 
substrate. The decrease in absorbance was monitored at 224 nm over 40 s taking readings 
every 1.5 s.  The rate was then calculated over the initial 20s period and plotted versus 
increasing substrate concentration. These data were then fit to the Michaelis-Menten 
equation, provided in the Grafit program (Erithacus Software Ltd.), to determine the 
values of kcat and Km for the enzyme in the presence of bromide.   
For NaCl, the enzyme solution (75 mL of a 2 µM solution in 20 mM-NaHCO3-
NaOH buffer, pH 9.0, that had equilibrated for 1 h at 22 °C) was divided into 3 25-mL 
aliquots.  Two portions of NaCl (2.215 mg and 8.863 mg) were added to two of the 
enzyme solutions to make a final chloride concentration of 2.5 mM and 10 mM, 






2.2.4 Stopped Flow Experiments Using cis-CaaD  
Stopped Flow Experiments Using cis-CaaD.  All stopped flow experiments and 
measurements were carried out using a SF 2004 series stopped flow apparatus from 
Kintek Corp. (http://www.kintek-corp.com). cis-CaaD (20 µM based on monomer 
molecular mass)  was made up in 20 mM Na2HPO4 buffer, pH 9.0, or 20 mM NaHCO3-
NaOH buffer, pH 9.0 (as indicated), and allowed to equilibrate at 22 °C for 1 h.  Various 
concentrations of cis-3-chloro- or cis-3-bromoacrylic acid (100-9,000 µM before mixing) 
were made up in 100 mM Na2HPO4 buffer, pH 9.0, or in 50 mM NaHCO3-NaOH buffer, 
pH 10.0. The addition of cis-3-chloro- or cis-3-bromoacrylic acid to the buffer adjusted 
the pH to ~7.8. The enzyme (10 µM after mixing) and substrate (50-4,500 µM after 
mixing) solutions were then mixed in the stopped flow apparatus at 22 °C. The pH after 
mixing was 7.8.  The samples were excited at 280 nm and fluorescence emission was 
monitored using a photomultiplier tube equipped with a 340 nm long pass Corion filter. 
In order to reduce photobleaching, the slit width on the xenon light source and the light 
filter were set at 3.16 mm. The high voltage output was set at 643 volts. Three time 
intervals (0.2 s, 2 s, and 12-180 s) were recorded for each substrate concentration. The 
length of the variable time interval (12-180 s) depended on the time needed for the 
fluorescence signal to return to its initial fluorescence value.  Each experiment was 
repeated 5 times. 
2.2.5 Control Experiments for Stopped Flow Analysis   
Fluorescence Quenching by Buffer.   cis-CaaD (20 µM based on monomer 
molecular mass)  was made up in 20 mM Na2HPO4 buffer, pH 9.0, and allowed to 
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equilibrate at 22 °C for 1 h.  The enzyme (10 µM after mixing) and 20 mM NaH2PO4 
buffer (10 µM after mixing), pH 9.0, were mixed in the stopped flow apparatus at 22 °C. 
The samples were excited at 280 nm and fluorescence emission was monitored using a 
photomultiplier tube equipped with a 340 nm long pass Corion filter.  Various 
combinations of the slit width on the light source and light filter, along with the HV 
settings, were used in order to detect a fluorescence signal. There was no detectable 
quenching by the buffer. 
Fluorescence Quenching by Malonate Semialdehyde and Bromide Ion. cis-CaaD 
and CaaD (20 µM based on monomer molecular mass)  were each made up in 2 mL of 20 
mM Na2HPO4 buffer, pH 9.0, and allowed to equilibrate at 22 °C for 1 h.  An 80-µL 
aliquot of CaaD (in 20 mM Na2HPO4 buffer, pH 9.0) was diluted into 720 µL of 20 mM 
Na2HPO4 buffer, pH 9.0, to give a final volume of 800 µL.  A 200-µL aliquot of trans-3-
chloroacrylic acid (from a 10 mM stock solution in 100 mM NaH2PO4 buffer, pH 9.0) 
was added to the enzyme solution and allowed to sit at 22 °C for 5 min.  Equal volumes 
of the reaction mixture were rapidly mixed with equal volumes of 20 µM cis-CaaD in 
Na2HPO4 buffer, pH 9.0, in the stopped flow apparatus at 22 °C.  The samples were 
excited at 280 nm and fluorescence emission was monitored using a photomultiplier tube 
equipped with a 340 nm long pass Corion filter.  Various combinations of the slit width 
on the light source and light filter, along with the HV settings, were used in order to 
detect a fluorescence signal.  There was not detectable quenching by malonate 




2.2.6 Buffer Exchange 
Buffer Exchange for Rapid Quench Experiments.  cis-CaaD is stored in 10 mM 
Tris-SO4 buffer, pH 9.0, at 4 °C.  The enzyme is exchanged into 20 mM NaHCO3-NaOH 
buffer, pH 9.0, by diluting ~1.2 mL (of a 12.75 mg/mL stock solution of cis-CaaD in 10 
mM Tris-SO4 buffer, pH 8.0) into 10 mL of 20 mM NaHCO3-NaOH buffer, pH 9.0, to 
give a final volume of ~11.2 mL.  The solution was then placed in an Amicon stirred cell 
equipped with a YM10 (10,000 MW cutoff) ultrafiltration membrane and concentrated to 
~1.2 mL.  The enzyme was then diluted with a 10 mL portion of 20 mM NaHCO3-NaOH 
buffer, pH 9.0, and concentrated to 1.2 mL. This procedure was repeated 4 times to 
ensure complete exchange of buffer. 
2.2.7 Rapid Chemical-Quench Flow Experiments Using cis-CaaD 
  Rapid Chemical-Quench Flow Measurements Using cis-CaaD and cis-3-
Bromoacrylic Acid.  The time course needed to measure the reaction between cis-CaaD 
and cis-3-bromoacrylic acid is too fast to measure by manually mixing and quenching. 
Hence, rapid quench experiments were carried using a quench-flow apparatus (RQF-3 
Rapid Quench Flow) from Kintek Corp (http://www.kintek-corp.com).  These reactions 
were carried out at 22 °C.  Typcially, one syringe was loaded with cis-CaaD (250, 500 or 
1000 µM made up in 20 mM NaCO3-NaOH buffer, pH 9.0).  Another syringe was loaded 
with freshly prepared 10,000 µM cis-3-bromoacrylic acid (made up in 50 mM NaHCO3-
NaOH buffer, pH 10.0).  Each reaction was initiated by the rapid mixing of aliquots (15 
µL) of the reactants from both syringes.  The reaction mixture was quenched at various 
intervals ranging from 3-750 ms with 80 µL of 0.6 M H2SO4. The amount of bromide 
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formed was then quantified using ion chromatography.  Kinetic parameters were derived 
by fitting the data to the appropriate equation by non-linear regression analysis.  
Preparation of Quenched Reaction Samples for Bromide Ion Analysis.  The 
individually quenched reaction mixtures were centrifuged at 1000 rpm for 5 s.  The 
supernatant from each sample was then transferred to a 1.5 mL ependorf tube equipped 
with 3,000 MW cutoff Microcon centrifugal filter devices.  The samples were centrifuged 
at 9,000 rpm for 50 min to remove the enzyme from the reaction mixture.  A 20-µL 
aliquot was diluted into 780 µL of 20 mM NaCO3-NaOH buffer, pH 9.0, to give a final 
volume of 800 µL.  The concentration of bromide was quantified using ion 
chromatography. 
Identification of Quench Conditions for the cis-CaaD-catalyzed Reaction.  
Various acids (CF3CO2H, HNO3, H2SO4, HPO4) were examined to determine which one 
terminated the reaction between cis-CaaD and cis-3-bromoacrylic acid.  The protocol to 
quantify bromide ion content, described below, was used for all four acids but is only 
described in detail for H2SO4.  A 50 mL stock solution of 1.5 M acid H2SO4 was made by 
mixing 4.14 mL of 18 M ultra pure H2SO4 with 45.83 mL of deionized water.  A 20 mM 
stock solution of cis-CaaD was then made up in 20 mM Na2HPO4 buffer, pH 9.0, and 
allowed to equilibrate for 1 h at 22 °C. A 8000 µM stock solution of cis-3-bromoacrylic 
acid in 100 mM Na2HPO4 buffer, pH 9.0, was also made up as described previously.  In a 
1.5 mL ependorf tube, 300 µL of 20 mM cis-CaaD solution was mixed with 300 µL of 
8000 µM cis-3-bromoacrylic acid and allowed to incubate at 22 °C.  After 10 s, sufficient 
H2SO4 (92.3 µL) was added to the reaction mixture to bring the final concentration of 
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acid to 0.2 M.  The reaction mixture was then divided into equal proportions and 
analyzed using ion chromatography. One portion was analyzed immediately and the other 
portion was analyzed 24 h later.  The same procedure was repeated, only changing the 
initial concentration of H2SO4 such that the final concentration acid was 0.3 M, 0.4 M, 
0.5 M, and 0.6 M. 
2.2.8 Quantification of Bromide Ion Concentration Using Ion Chromatography 
 Quantification of Bromide Ion Concentration Using Ion Chromatography.  A 
400-µL portion of each quenched mixture was loaded into 500 µL sample vials (Dionex) 
and placed in an AS40 autosampler. Only 10 µL of sample from each vial was loaded 
onto the AS12A column by the autosampler.  The column had been previously 
equilibrated with 2.7 mM Na2CO3/0.3 mM NaHCO3 buffer, pH 9.6. The contents of the 
mixture were eluted isocratically (1.5 mL/min) over 15 min.  The bromide ion was 
detected by supressed conductivity using an electrochemical detector with an applied 
current of 100 mA.  The quench samples were alternated with deionized water samples 
(400 µL) in order to elute any remaining anions from the column before loading the next 
sample. 
Calibration Curve for Ion Chromatography.  The calibration curve used in 
bromide analysis was constructed using 8 known concentrations of bromide (0-10 ppm) 
made from a stock solution of KBr (12.51 mM, 1000 ppm Bromide ion) in 2.7 mM 
Na2CO3/0.3 mM NaHCO3 buffer, pH 9.6.  The stock solution of KBr was made by 
dissolving KBr (148.93 mg) in 100 mL of 2.7 mM Na2CO3/0.3 mM NaHCO3 buffer, pH 
9.6, giving a final bromide concentration of 1000 mg/L. A 10 ppm solution of bromide 
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(10 mL) was made from the stock solution by diluting 100 µL into 9900 µL of 
Na2CO3/0.3 mM NaHCO3 buffer, pH 9.6.  This solution was then used to make 7 
solutions (2 mL) with the following concentrations of bromide: 5 ppm, 2.5 ppm, 1.25 
ppm, 0.625 ppm, 0.3125 ppm, 0.0156 ppm, and 0 ppm (2 mL of Na2CO3/0.3 mM 
NaHCO3, pH 9.6). 
2.3 Results and Discussion 
2.3.1 Purification and Characterization of cis-CaaD 
 Purification and Characterization of cis-CaaD.  The gene encoding cis-CaaD was 
expressed under the control of the T7 promoter and the enzyme was purified to 
homogeneity by a variation of published protocols (9).  This protocol yielded ~ 100 mg 
of purified enzyme from 2 L of cell culture.  ESI-MS analysis of the purified protein 
showed a mass of 16,622 Da, indicating that the initiating N-formyl methionine had been 
post-translationally removed from the protein.  Hence, Pro-1 is available for catalysis.   
2.3.2 Steady-State Kinetic Parameters for cis-CaaD 
Determination of the Steady-State Kinetic Parameters for cis-CaaD.  The steady 
state kinetic parameters for cis-CaaD using cis-3-chloro and cis-3-bromoacrylate were 
measured in three buffer systems, 20 mM Na2HPO4 buffer (9), 20 mM Tris-H2SO4 buffer, 
and 20 mM NaHCO3-NaOH buffer.  The pH of all three buffers was adjusted to pH 9.0.  
The results of these experiments provided the necessary framework for the pre-steady 
state analysis.  The values of Km and kcat (Table 1) for both cis-3-chloro- and cis-3-
bromoacrylic acid were similar in the Na2HPO4 and Tris buffers (data not shown), but 
decreased in the NaHCO3 buffer.  For cis-3-bromoacrylate, the values of Km and kcat 
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showed 1.5- and 2.3-fold decreases, respectively.  This resulted in a 3.3-fold decrease in 
the value of kcat/Km.  The Km and kcat values for cis-3-chloroacrylic acid were not 
determined in NaHCO3 buffer. 
 
Table 1.  Steady-State Kinetic Parameters for cis-CaaD 
 
substrate     kcat    Km   kcat/Km 
      (s-1)             (µM)             (M-1 s-1) 
 
 
cis-3-Chloroacrylic Acida  5.9 ± .1         200 ± 15                     2.9 × 104 
 
cis-3-Bromoacrylic Acida  5.4 ± .2         200 ± 17                     2.7 × 104 
cis-3-Bromoacrylic Acidb       2.4 ± 0.1         300 ± 32                     8.1 × 103  
 
 
aThe steady-state kinetic parameters were determined in 20 mM sodium phosphate buffer 
(pH 9.0) at 22 °C.  Errors are standard deviations. 
 
bThe steady-state kinetic parameters were determined in 20 mM sodium bicarbonate 
buffer (pH 9.0) at 22 °C.  Errors are standard deviations. 
 
 
2.3.3 Inhibition of cis-CaaD by Halide Ion. 
Inhibition of cis-CaaD by Halide Ion.  In the presence of 2.5 and 10 mM bromide 
ion, kcat dropped 1.6-fold and 2.1-fold, respectively.  In the presence of 2.5 and 10 mM 
chloride ion, there was no significant decrease in the kcat (within experimental error).  The 
values of Km were not affected.  These observations suggest that bromide ion exhibits a 
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non-competitive type of inhibition on cis-CaaD (Figure 2.1).  The purpose of this 
experiment was to determine whether halide ion binds at the active site, perhaps 
indicative of a halide binding pocket.  The results suggest that it does not.  
 






















Figure 2.1.  Noncompetitive inhibition of cis-CaaD by bromide (0 mM, filled circles; 2.5 
µM, filled squares; and 10 µM, filled triangles) using cis-chloroacrylic acid (10-800 µM) 
as substrate in NaHCO3-NaOH buffer, pH 9.0, at 22 °C.   
 
2.3.4 Quantification of Bromide Ion Concentration Using Ion Chromatography 
Quantification of Bromide Ion Concentration Using Ion Chromatography.  The 
bromide ion concentration in the burst experiments was quantified by ion 
chromatography.  A series of control experiments was carried out (Figures 2.2-2.7) to 
validate the methodology.  The individual components of a burst experiment (buffer, cis-
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3-bromoacrylate, bromide ion, and sulfate ion) were individually eluted from the column 
and their elution times identified (Figures 2.2-2.5).  Subsequently, the mixed components 
were eluted at two different concentrations of bromide ion (10 and 2 ppm).  The 
chromatograph (Figure 2.6) for the mixture containing 10 ppm bromide ion shows clear 
separation of these components using 2.7 mM Na2CO3/0.3 mM NaHCO3, pH 9.6, as the 
eluent at a flow rate of 1.5 mL/min. The chromatograph (Figure 2.7) for the mixture 
using 2 ppm bromide ion also shows clear separation under the same conditions.  Finally, 
a chromatograph (Figure 2.8) from a typical quenched reaction mixture is shown.  Again, 
there is clear separation of bromide ion from the components of the reaction mixture. 
Separation could only be achieved using the NaHCO3 buffer because the signal generated 
by the phosphate ion from the sodium phosphate buffer overlapped with the signal from 
the bromide ion  (data not shown).   The detection limits ranged from a low of 7.5 ppb 










Figure 2.2.  Ion chromatograph of 20 mM NaHCO3-NaOH buffer, pH 9.0, as analyzed 















Figure 2.3.  Ion chromatograph of 25 ppm of cis-3-bromoacrylic acid in 20 mM 
NaHCO3-NaOH buffer, pH 9.0, eluted over a 15-min period at 22 °C.  The prominent 













Figure 2.4.  Ion chromatograph of 25 ppm of bromide in 20 mM NaHCO3-NaOH buffer, 
pH 9.0, eluted over a 15-min period at 22 °C.  The prominent signal at 6.647 min 














Figure 2.5.  Ion chromatograph of 25 ppm of sulfate from Na2SO4 in 20 mM NaHCO3-
NaOH buffer, pH 9.0, eluted over a 15-min period at 22 °C.  The prominent signal at 














Figure 2.6.  Ion chromatograph of cis-3-bromoacrylic acid (25 ppm), bromide (10 ppm), 
and sulfate (25 ppm) in 20 mM NaHCO3-NaOH buffer, pH 9.0, eluted over a 15-min 
period at 22 °C.  The signals at 2.834 min, 6.660 min, and 12.357 min correspond to cis-









Figure 2.7.  Ion chromatograph of cis-3-bromoacrylic acid (25 ppm), bromide (2 ppm), 
and sulfate (500 ppm) in 20 mM NaHCO3-NaOH buffer, pH 9.0, eluted over a 15-min 
period at 22 °C (top panel).  The signal at 6.670 min corresponds to bromide and the 
signal at 11.860 min corresponds to sulfate.  A blow-up of the chromatograph showing 










Figure 2.8.  Ion chromatograph of a quenched reaction mixture from a rapid quench 
experiment with cis-CaaD (500 µM) and cis-3-bromoacrylic acid (5000 µM) in 20 mM 
NaHCO3-NaOH buffer, pH 9.0, at 22 °C.  The reaction was quenched after 0.075 sec 
with 0.6 M H2SO4 and analyzed.  The signal at 2.834 min corresponds to cis-3-
bromoacrylic acid, the signal at 7.233 min corresponds to bromide (0.099 ppm), and the 
signal at 11.092 min corresponds to sulfate.  A blow-up of the chromatograph showing 





2.3.5 Rapid Chemical-Quench Flow Experiments 
  Rapid Chemical-Quench Flow Experiments Using cis-CaaD.   In order to identify 
the rate-limiting step, pre-steady state burst experiments were conducted on the cis-CaaD 
reaction.  Three experiments were initiated by mixing different concentrations of cis-
CaaD (final concentrations 125 µM, 250 µM, and 500 µM) with an excess of cis-3-
bromoacrylic acid (final concentration 5 mM).  At fixed time intervals (3-750 ms), the 
reactions were quenched and the amount of bromide ion quantified.  A pre-steady state 
burst of product (i.e., bromide ion) was observed in all three experiments when the 
concentration of bromide ion was plotted versus time (Figures 2.9-2.12) with a fast initial 
rate followed by a slower steady-state rate of product formation.  The data can be fit to a 
burst equation (equation 1), 
C t k  Ae Y 2
t)(-k1 ++=     (1) 
where Y is the bromide ion concentration, A is the amplitude of the burst, k1 is the burst 
rate constant, k2 is the steady-state rate constant, and C is the offset constant (17).  The 
exponential burst rate constants (i.e., k1) are 41.4 ± 7.8 s-1, 36.2 ± 4.5 s-1, 24.4 ± 1.8 s-1 for 
the experiments using 125, 250, 500 µM enzyme, respectively.   The steady-state rate 
constants for the same experiments are 3.8 s-1, 3.6 s-1 and 5.0 s-1, respectively.  The 
steady-state rate constants were determined by dividing k2 by the active enzyme 
concentrations, obtained from the amplitude of the burst.  These values are in good 
agreement with the steady-state kcat values reported (in Table 1) above for cis-CaaD and 
cis-3-bromoacrylate (in 20 mM Na2HPO4 and NaHCO3 buffers at pH 9.0).  The active 
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enzyme concentration obtained in these experiments corresponded to ~66% of that 
determined by the Waddell method (15).   
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Figure 2.9.  Rapid quench experiment using 125 µM cis-CaaD with 5000 µM cis-3-
bromoacrylic acid in 20 mM NaHCO3-NaOH buffer, pH 9.0, at 22 °C.  The reported 
concentrations are those after mixing enzyme and substrate.  The reaction shows a burst 































Figure 2.10.  Rapid quench experiment using 250 µM cis-CaaD with 5000 µM cis-3-
bromoacrylic acid in 20 mM NaHCO3-NaOH buffer, pH 9.0, at 22 °C.  The reported 
concentrations are those after mixing enzyme and substrate.  The reaction shows a burst 
































Figure 2.11.  Rapid quench experiment using 500 µM cis-CaaD with 5000 µM cis-3-
bromoacrylic acid in 20 mM NaHCO3-NaOH buffer, pH 9.0, at 22 °C.  The reported 
concentrations are those after mixing enzyme and substrate.  The reaction shows a burst 





























Figure 2.12.  Rapid quench experiments using 125 µM (solid circles), 250 µM (solid 
squares), and 500 µM (solid triangles) cis-CaaD with 5,000 µM cis-3-bromoacrylic acid 
in 20 mM NaHCO3-NaOH buffer, pH 9.0, at 22 °C.  The reported concentrations are 
those after mixing enzyme and substrate.  The reactions show a burst of bromide 
formation followed by a steady-state rate.   
 
  The presence of a pre-steady state burst indicates that a step after chemistry is rate 
limiting, presumably product release.   Hence, we propose that the product formation at 
the active site is fast, but is followed by a slow release of bromide ion.  The burst rate 
obtained from fitting the data is a sum of the rates of the chemical reaction and the 
product release.  In the case of the three burst reactions, the burst rate is much faster than 
the steady state turnover rate, suggesting that the burst rates are dominated by the 
chemical reaction.  The chemical reaction includes all steps up to, and including product 
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formation.  This includes substrate binding, any conformational changes that occur within 
the enzyme upon substrate binding, and chemistry (e.g., the formation of 7 and 8 in 
Scheme 2).   
2.3.6 Stopped Flow Kinetic Experiments  
  Stopped Flow Kinetic Experiments.  In order to determine whether cis-CaaD 
undergoes a conformational change upon substrate binding, stopped flow experiments 
were carried out by following the changes in tryptophan fluorescence upon substrate 
binding.  There are two tryptophans in cis-CaaD, Trp-101 and Trp-128 (11).  According 
to the crystal structures, Trp-101 is in the active site, and Trp-128 is on the surface.  The 
tryptophan at the active site could report the conformational changes of the enzyme 
during substrate binding and catalysis (17).  























Figure 2.13.  Traces from 17 stopped-flow experiments in which cis-CaaD (10 µM) in 20 
mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of cis-3-bromoacrylic 
acid (50-4500 µM, top to bottom) at 22 °C.  The decrease in fluorescence was fit to a 
double exponential. The signals returned to the initial fluorescence value at times ranging 
from 10-200 s. The reported concentrations are those after mixing enzyme and substrate.  

























Figure 2.14.  Two representative traces from 17 stopped-flow experiments in which cis-
CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of 
cis-3-bromoacrylic acid (400 µM and 500 µM, top to bottom) at 22 °C.  These two traces 
show the return to the initial fluorescence value after 35 s. The reported concentrations 
























Figure 2.15. Concentration dependence of kobs for binding of cis-3-bromoacrylic acid 
(50–4500 µM) to cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 °C.  The 
concentration dependence of the fast phase was fit to an equation for a hyperbola.  The 




























Figure 2.16.  Concentration dependence of kobs for binding of cis-3-bromoacrylic acid 
(50–4500 µM) to cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 °C.  The 
concentration dependence of the slow phase was fit to an equation for a hyperbola.  The 




























Figure 2.17.  Concentration dependence of the amplitude for the fast phase binding of cis-
3-bromoacrylic acid (50–4500 µM) to cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 
9.0, at 22 °C.  The concentration dependence of the amplitude was fit to an equation for a 



























Figure 2.18.  Concentration dependence of the amplitude for the slow phase binding of 
cis-3-bromoacrylic acid (50–4500 µM) to cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, 
pH 9.0, at 22 °C. The data could not be fit. The reported concentrations are those after 
mixing enzyme and substrate. 
 
 In these experiments, cis-CaaD was mixed with increasing concentrations of cis-
3-chloro- or cis-3-bromoacrylic in 20 mM Na2HPO4 or 20 mM NaHCO3 buffer, pH 9.0, 
as indicated.  The results for the stopped flow kinetic experiments using cis-3-
bromoacrylic acid are shown in Figures 2.13-2.18. (The results for the stopped flow 
kinetic experiments using cis-3-chloroacrylic acid can be found in the supplement to this 
chapter.)  Each trace shows a rapid decrease in fluorescence followed by a slow decrease 
in fluorescence.  The decay in fluorescence can be fit to a double exponential equation to 
yield rates, (kobs), and amplitudes for the fast and slow phases (17).  The values for kobs 
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for the fast phase were plotted versus the concentrations of substrate.  The data can be fit 











=      (2) 
where kobs is the observed rate, kfor is the forward reaction rate of the conformational 
change, krev is the reverse reaction rate of the conformational change, [S] is the 
concentration of substrate, and Kd is the binding constant.  This fit yields a Kd of 1366 ± 
300 µM and a maximum kobs of 136 s-1 (the sum of kfor of 89 s-1 and krev of 47 s-1) for cis-
CaaD with cis-3-bromoacrylic acid.  The same experiments were conducted in 20 mM 
NaHCO3-NaOH buffer, pH 9.0, using cis-3-bromoacrylic acid. However, at high 
concentrations of substrate (>3500 µM) the fluorescence signals were not reproducible so 
that reliable rate constants could not be determined.  For cis-3-chloracrylic acid in 20 mM 
phosphate buffer, pH 9.0, this analysis gives a Kd of 1101 ± 137 µM, a maximum kobs of 
103 s-1 (sum of kfor of 95 s-1 and krev of 8 s-1) (data shown in supplement). 
 The slow rates were also plotted versus the concentrations of substrate.  The data 
can be fit to an equation for a hyperbola (equation 2) and gives a Kd of 151 ± 21 µM, a 
maximum kobs of 3.4 s-1 ( sum of kfor of 1.5 s-1 and krev of 1.9 s-1 ) for cis-CaaD with cis-3-
bromoacrylic acid, and a Kd of 130 ± 21 µM, a maximum kobs of 3.2 s-1 (sum of kfor of 1.5 
s-1 and krev of 1.7 s-1 ) with cis-3-chloroacrylic acid in 20 mM phosphate buffer, pH 9.0 
(data shown in supplement). 
 The concentration dependence of the rates and amplitudes of the reaction mirrors 
changes in the kinetics of substrate binding.  The hyperbolic behavior suggests a two-step 
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mechanism that approaches a maximum rate and is limited by a first order isomerization 
(i.e., conformational change) of the enzyme-substrate complex (17).  This suggests that 
cis-CaaD binds cis-3-bromoacrylic acid in the first step (with a Kd of ~1400 µM) and 
then the complex undergoes a change in conformation. 
2.3.7 Proposed Kinetic Mechanism for cis-CaaD 
Data Analysis and Computer Simulation.  The combination of the rapid quench 
and stopped flow kinetic experiments allows a determination of the rates for a five-step 
reaction mechanism (Scheme 3) by global fitting and computer simulation.  Stopped flow 
kinetic experiments provide information about the rates of substrate binding, and rapid 
quench experiments provide information about the rest of the reaction.  Accordingly, two 
data sets were fit globally using the KinTek Global Kinetic Explorer program.  The first 
data set consisted of the two burst experiments carried out with cis-CaaD (125 and 250 
µM) and cis-3-bromoacrylic acid (5000 µM) in 20 mM NaHCO3 buffer, pH 9.0 (Figure 






















Figure 2.19.  Burst kinetics of cis-CaaD with cis-3-bromoacrylic acid (125 µM filled 
circles, 250 µM filled triangles) in 20 mM NaHCO3 buffer, pH 9.0.  Simulated curves at 
125 µM and 250 µM are shown in blue and red, respectively.  
 
The second data set consisted of four stopped flow fluorescence traces carried out with 
cis-CaaD (10 µM) and cis-3-bromoacrylic acid (1000 µM, 1250 µM, 1500 µM, and 2000 
µM after mixing) in 20 mM NaHCO3 buffer, pH 9.0 (Figure 2.20).  The data obtained in 
the NaHCO3 buffer were used in the simulation experiments because the rapid quench 
reactions were carried out in this buffer.  The fluorescence signals at these four 

















Figure 2.20.  Stopped flow fluorescence traces with cis-CaaD (10 µM) and cis-3-
bromoacrylic acid (1000 µM, red; 1250 µM, green; 1500 µM, blue; 2000 µM, purple) in 
20 mM NaHCO3 buffer, pH 9.0.  The black lines represent the simulated traces.  
 
These two data sets can be fit to a five-step mechanism (Scheme 3) where the 
enzyme binds the substrate, followed by a conformational change to FS, followed  by fast 
product formation to EPQ, and then a slow release of one product P, followed by fast  
release of a second product Q . 
 
Scheme 3  












The rate constants shown in Scheme 3 were estimated by the computer simlution of the 
two burst experiments and the four stopped-flow experiments. In the simulation, it was 
assumed that product formation is irreversible (k-3).  It was also assumed that product 
binding to free enzyme was negligible. The simulation was carried out by a trial and error 
process.  However, the fit was constrained by the experimentally determined kfor and krev 
from the fast phase of the stopped flow experiment.   
 A kcat of 29 s-1 was calculated from these simulated rate constants (17). This value 
does not agree with the value measured experimentally for cis-3-bromoacrylic acid (~2.7 
s-1).  However, the value of k-4 (the binding of P to EQ) is concentration dependent.  
When this concentration dependence is factored into the calculation, the kcat value 
becomes ~5 s-1, which is in reasonable agreement with the experimentally determined 
value.  According to the model, the build up of bromide ion inhibits product release from 
the EPQ complex, thereby making product release rate limiting.   
2.4 Summary:  Analysis and Implications 
Our results clearly show that cis-CaaD is amenable to pre-steady state kinetic 
analysis, and a minimal kinetic model has been obtained.  In addition, the Y103F and 
E114Q mutants of cis-CaaD can be analyzed by both stopped flow and rapid quench 
methods.  These experiments are currently being pursued and will provide insight into the 
mechanism for the addition of water to substrate.  Stopped-flow kinetic analysis of the 
P1A mutant of cis-CaaD shows non-interpretable fluorescence decay.  This mutant may 
“damage” the active site such that events at the active site cannot be reliably monitored 
by Trp-101.  Finally, the R70A-, R73A-, and H28A-cis-CaaD show no fluorescence 
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change upon substrate binding.  These observations could suggest that the substrate 
doesn’t bind to these mutants or binds very weakly (> 5 mM), thereby accounting for the 
observed lack of activity.  These residues are currently being investigated using more 
conservative mutations (e.g., the R70K-, R73K-, and H28Q-cis-CaaD). 
The observation that bromide release is the rate limiting step in the cis-CaaD-
catalyzed reaction could argue for or against the presence of a halide binding pocket.  A 
halide binding pocket is identified by crystallographic analysis, competitive inhibition by 
halide, and fluorescence quenching by halide.  The purpose of the pocket is to assist the 
cleavage of the carbon-halogen bond and stabilization of the negative charge of the halide 
product.  For example, in haloalkane dehalogenase, two tryptophan residues (Trp-125 and 
Trp-175) form hydrogen bonds with chloride, as shown by crystallographic studies (13a, 
d).  Before another turnover can occur the halide, in this case chloride, must leave the 
binding pocket.  Burst experiments on the haloalkane dehalogenase show halide release is 
rate limiting and suggested that “escape’ of the halide from the pocket limits the overall 
reaction.  In the W175Y mutant, halide release is accelerated and no longer rate limiting.  
It was suggested that this mutation allowed the halide to “escape” more easily from the 
pocket (18). 
In cis-CaaD (and CaaD), a halide-binding pocket may not be necessary.  
Examination of Scheme 2 shows that addition of water to substrate results in three 
unstable species, the enediolate species, the halohydrin 5, and the enol intermediate 6.  
These putative intermediates may not need much catalysis for decay.  The lifetime of the 
enediolate in water should be even shorter than the lifetime of ~10-9 s for the enolate of 
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ethyl acetate (19).  The lifetimes of 5 and 6 are longer but still require little catalysis for 
decay.  Although a halide binding pocket may not be necessary and may not be present, 
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Supplement to Chapter 2:  Purification, Characterization, and Pre-




 The supplement contains the purification protocols for the P1A-, H28A-, R70A-, 
R73A-, Y103F-, and E114Q-mutants of cis-CaaD, and steady-state kinetic parameters for 
the Y103F- and E114Q-mutants.  In addition, it reports the stopped-flow kinetic 
experiments for the six cis-CaaD mutants using cis-3-chloro- and cis-3-bromoacrylic 
acid, as indicated.  Some additional data obtained for the wild type enzyme is included.  
Where possible, the decays in fluorescence have been fit to double or single exponentials.  
The kobs and amplitudes have also been determined and plotted versus substrate 
concentration where possible.  The apparent Kd values and rate constants are reported.  
Finally, the rapid chemical quench experiment for the E114Q mutant of cis-CaaD, 
analysis of the burst, and derived rate constants are reported. 
S.2.2 Materials and Methods 
 The materials and methods used in the supplement are described in the parent 
chapter. 
S.2.2.1 Transformation, Expression and Purification of cis-CaaD Mutants 
Expression and Purification of P1A-cis-CaaD.  The pCC5 plasmid containing the 
P1A-cis-CaaD gene (9) was transformed as described in the parent chapter for the wild 
type cis-CaaD gene into E. coli BL21-Gold(DE3) cells for protein expression.  The gene 
product was expressed using the T7 expression system as described for wild type.  
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Typically 1 L of culture yields 5 g of cells which were frozen until ready for use.  The 
cells (~10g) were thawed and processed following the protocol described for lysis of wild 
type cells and subsequent protein purification.  Fractions from the TSKgel DEAE-5PW 
anion-exchange column (#4-18) with the highest purity (as determined by SDS-PAGE) 
were pooled and concentrated to ~20 mL using an Amicon stirred cell equipped with a 
YM10 (10,000 MW cutoff) ultrafiltration membrane.  Fractions from the TSKgel Phenyl-
5PW column (#9-12) with the highest purity (as determined by SDS-PAGE) were pooled 
and concentrated to ~4.5 mL using an Amicon stirred cell equipped with a YM10 (10,000 
MW cutoff) ultrafiltration membrane and stored at 4 °C.  This purification resulted in ~70 
mg of 95% pure protein as assessed by ESI mass spectroscopy and SDS-PAGE. The 
observed monomer mass for P1A-cis-CaaD was 16,595 Da. 
Expression and Purification of H28A-cis-CaaD.  The pCC5 plasmid containing 
the H28A-cis-CaaD gene (11) was transformed as described in the parent chapter for the 
wild type cis-CaaD gene into E. coli BL21-Gold(DE3) cells for protein expression.  The 
gene product was expressed using the T7 expression system as described for wild type.  
Typically 1 L of culture yields 5 g of cells which were frozen until ready for use.  The 
cells (~10g) were thawed and processed following the protocol described for lysis of wild 
type cells and subsequent protein purification.  Fractions from the TSKgel DEAE-5PW 
anion-exchange column (#12-34) with the highest purity (as determined by SDS-PAGE) 
were pooled and concentrated to ~20 mL using an Amicon stirred cell equipped with a 
YM10 (10,000 MW cutoff) ultrafiltration membrane.  Fractions from the TSKgel Phenyl-
5PW column (#22-25) with the highest purity (as determined by SDS-PAGE) were 
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pooled and concentrated to ~2 mL using an Amicon stirred cell equipped with a YM10 
(10,000 MW cutoff) ultrafiltration membrane and stored at 4 °C.  This purification 
resulted in ~25 mg of 90% pure protein as assessed by ESI mass spectroscopy and SDS-
PAGE. The observed monomer mass for H28A-cis-CaaD was 16,554 Da. 
Expression and Purification of R70A-cis-CaaD.  The pCC5 plasmid containing 
the R70A-cis-CaaD gene (9) was transformed as described in the parent chapter for the 
wild type cis-CaaD gene into E. coli BL21-Gold(DE3) cells for protein expression.  The 
gene product was expressed using the T7 expression system as described for wild type.  
Typically 1 L of culture yields 5 g of cells which were frozen until ready for use.  The 
cells (~10g) were thawed and processed following the protocol described for lysis of wild 
type cells and subsequent protein purification.  Fractions from the TSKgel DEAE-5PW 
anion-exchange column (#12-34) with the highest purity (as determined by SDS-PAGE) 
were pooled and concentrated to ~20 mL using an Amicon stirred cell equipped with a 
YM10 (10,000 MW cutoff) ultrafiltration membrane.  Fractions from the TSKgel Phenyl-
5PW column (#20-22) with the highest purity (as determined by SDS-PAGE) were 
pooled and concentrated to ~4.5 mL using an Amicon stirred cell equipped with a YM10 
(10,000 MW cutoff) ultrafiltration membrane and stored at 4 °C.  This purification 
resulted in ~70 mg of 95% pure protein as assessed by ESI mass spectroscopy and SDS-
PAGE. The observed monomer mass for R70A-cis-CaaD was 16,534 Da. 
Expression and Purification of R73A-cis-CaaD.  The pCC5 plasmid containing 
the R73A-cis-CaaD gene (9) was transformed as described in the parent chapter for the 
wild type cis-CaaD gene into E. coli BL21-Gold(DE3) cells for protein expression.  The 
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gene product was expressed using the T7 expression system as described for wild type.  
Typically 1 L of culture yields 5 g of cells which were frozen until ready for use.  The 
cells (~10g) were thawed and processed following the protocol described for lysis of wild 
type cells and subsequent protein purification.  Fractions from the TSKgel DEAE-5PW 
anion-exchange column (#12-34) with the highest purity (as determined by SDS-PAGE) 
were pooled and concentrated to ~20 mL using an Amicon stirred cell equipped with a 
YM10 (10,000 MW cutoff) ultrafiltration membrane.  Fractions from the TSKgel Phenyl-
5PW column (#19-21) with the highest purity (as determined by SDS-PAGE) were 
pooled and concentrated to ~6 mL using an Amicon stirred cell equipped with a YM10 
(10,000 MW cutoff) ultrafiltration membrane and stored at 4 °C.  This purification 
resulted in ~120 mg of 90% pure protein as assessed by ESI mass spectroscopy and SDS-
PAGE. The observed monomer mass for R73A-cis-CaaD was 16,534 Da. 
Expression and Purification of Y103F-cis-CaaD.  The pCC5 plasmid containing 
the Y103F-cis-CaaD gene (11) was transformed as described in the parent chapter for the 
wild type cis-CaaD gene into E. coli BL21-Gold(DE3) cells for protein expression.  The 
gene product was expressed using the T7 expression system as described for wild type.  
Typically 1 L of culture yields 5 g of cells which were frozen until ready for use.  The 
cells (~10g) were thawed and processed following the protocol described for lysis of wild 
type cells and subsequent protein purification.  Fractions from the TSKgel DEAE-5PW 
anion-exchange column (#18-30) with the highest purity (as determined by SDS-PAGE) 
were pooled and concentrated to ~20 mL using an Amicon stirred cell equipped with a 
YM10 (10,000 MW cutoff) ultrafiltration membrane.  Fractions from the TSKgel Phenyl-
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5PW column (#20-22) with the highest purity (as determined by SDS-PAGE) were 
pooled and concentrated to ~15 mL using an Amicon stirred cell equipped with a YM10 
(10,000 MW cutoff) ultrafiltration membrane and stored at 4 °C.  This purification 
resulted in ~300 mg of 95% pure protein as assessed by ESI mass spectroscopy and SDS-
PAGE. The observed monomer mass for Y103F-cis-CaaD was 16,605 Da. 
Expression and Purification of E114Q-cis-CaaD.  The pCC5 plasmid containing 
the E114Q-cis-CaaD gene (9) was transformed as described in the parent chapter for the 
wild type cis-CaaD gene into E. coli BL21-Gold(DE3) cells for protein expression.  The 
gene product was expressed using the T7 expression system as described for wild type.  
Typically 1 L of culture yields 5 g of cells which were frozen until ready for use.  The 
cells (~10g) were thawed and processed following the protocol described for lysis of wild 
type cells and subsequent protein purification.  Fractions from the TSKgel DEAE-5PW 
anion-exchange column (#11-32) with the highest purity (as determined by SDS-PAGE) 
were pooled and concentrated to ~20 mL using an Amicon stirred cell equipped with a 
YM10 (10,000 MW cutoff) ultrafiltration membrane.  Fractions from the TSKgel Phenyl-
5PW column (#10-15) with the highest purity (as determined by SDS-PAGE) were 
pooled and concentrated to ~6 mL using an Amicon stirred cell equipped with a YM10 
(10,000 MW cutoff) ultrafiltration membrane and stored at 4 °C.  This purification 
resulted in ~130 mg of 95% pure protein as assessed by ESI mass spectroscopy and SDS-





S.2.2.2 Steady-State Kinetic Parameters for  cis-CaaD Mutants 
 The steady-state kinetic parameters for the E114Q and Y103F mutants of cis-
CaaD were measured as described for wild type in the parent chapter using cis-3-chloro- 
and cis-3-bromoacrylic acid.  The assay was initiated by the addition of substrate (10-700 
µM for E114Q-cis-CaaD and 1.5-100 µM for Y103F-cis-CaaD).  The data were analyzed 
as described for wild type in the parent chapter. 
S.2.2.3 Stopped Flow Experiments With cis-CaaD Mutants 
Stopped Flow Experiments With the E114Q Mutant of cis-CaaD.  The stopped 
flow experiments with the E114Q mutant of cis-CaaD were carried out as described in 
the parent chapter for wild type cis-CaaD in 20 mM Na2HPO4 buffer, pH 9.0.  cis-3-
Chloro- and cis-3-bromoacrylic acid (100-50,000 µM before mixing) were made up as 
described for wild type.  In order to reduce photobleaching, the slit width on the xenon 
light source and the light filter were set at 3.16 mm. The high voltage output was set at 
600 volts.  Three time intervals (3.5, 15, and 30s) were recorded for each substrate 
concentration.  Each experiment was repeated 5 times. 
Stopped Flow Experiments With the Y103F Mutant of cis-CaaD.  The stopped 
flow experiments with the Y103F mutant of cis-CaaD were carried out as described in the 
parent chapter for wild type cis-CaaD in 20 mM Na2HPO4 buffer, pH 9.0.  cis-3-Chloro- 
and cis-3-bromoacrylic acid (25-15,000 µM before mixing) were made up as described 
for wild type.  In order to reduce photobleaching, the slit width on the xenon light source 
and the light filter were set at 1.56 mm. The high voltage output was set at 753 volts.  
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Three time intervals (1, 2, and 10s) were recorded for each substrate concentration.  Each 
experiment was repeated 5 times. 
Stopped Flow Experiments With the P1A Mutant of cis-CaaD.  The stopped flow 
experiments with the P1A mutant of cis-CaaD were carried out as described in the parent 
chapter for wild type cis-CaaD in 20 mM Na2HPO4 buffer, pH 9.0.  cis-3-Chloro- and 
cis-3-bromoacrylic acid (25-100,000 µM before mixing) were made up as described for 
wild type.  In order to reduce photobleaching, the slit width on the xenon light source and 
the light filter were set at 1.56 mm. The high voltage output was set at 710 volts.  Three 
time intervals (2, 20, and 600s) were recorded for each substrate concentration.  Each 
experiment was repeated 5 times. 
Stopped Flow Experiments With the H28A, R70A, and R73A Mutants of cis-
CaaD.  The stopped flow experiments with the H28A, R70A, and R73A mutants of cis-
CaaD were carried out as described in the parent chapter for wild type cis-CaaD in 20 
mM Na2HPO4 buffer, pH 9.0, using 20 and 50 µM enzyme.  cis-3-Chloro- and cis-3-
bromoacrylic acid (25-100,000 µM before mixing) were made up as described for wild 
type.  Various combinations of the slit width on the light source and light filter, along 
with the HV settings, were used in order to detect a fluorescence signal.   
S.2.2.4 Rapid Chemical-Quench Experiment With E114Q-cis-CaaD 
 Rapid Chemical-Quench Flow Measurements Using E114Q-cis-CaaD and cis-3-
Bromoacrylic Acid.  The rapid quench experiments were carried using a quench-flow 
apparatus (RQF-3 Rapid Quench Flow) from Kintek Corp (http://www.kintek-corp.com).  
These reactions were carried out at 22 °C.  Typcially, one syringe was loaded with 
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E114Q-cis-CaaD (2000 µM made up in 20 mM NaCO3-NaOH buffer, pH 9.0).  Another 
syringe was loaded with freshly prepared 50,000 µM cis-3-bromoacrylic acid (made up in 
50 mM NaHCO3-NaOH buffer, pH 10.0).  Each reaction was initiated by the rapid 
mixing of aliquots (15 µL) of the reactants from both syringes.  The reaction mixture was 
quenched at various intervals ranging from 10 ms – 4 min with 80 µL of 0.6 M H2SO4. 
The amount of bromide formed was then quantified using ion chromatography.  Kinetic 


















S.2.3 Data and Results 
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Figure S.2.3.1.  Traces from 17 stopped-flow experiments in which cis-CaaD (10 µM) in 
20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of cis-3-chloroacrylic 
acid (50-4500 µM, top to bottom) at 22 °C.  The decrease in fluorescence was fit to an 
equation for a double exponential.  The signals return to the initial fluorescence value at 
times ranging from 10-180 s.  The reported concentrations are those after mixing enzyme 























Figure S.2.3.2.  Three representative traces from a total of 17 stopped-flow experiments 
in which cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal 
volume of cis-3-chloroacrylic acid (150 µM, 200 µM, and 250 µM, top to bottom) at 22 
°C.  These reactions were monitored for 30 s to show the return to the initial fluorescence 























Figure S.2.3.3.  Concentration dependence of kobs for binding of cis-3-chloroacrylic acid 
(50–4500 µM) to cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 °C.  The 
concentration dependence of the fast phase was fit to an equation for a hyperbola.  The 



























Figure S.2.3.4.  Concentration dependence of kobs for binding of cis-3-chloroacrylic acid 
(50–4000 µM) to cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 °C.  The 
concentration dependence of the slow phase was fit to an equation for a hyperbola.  The 



























Figure S.2.3.5.  Concentration dependence of the amplitude for the fast phase binding of 
cis-3-chloroacrylic acid (50–4000 µM) to cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, 
pH 9.0, at 22 °C.  The concentration dependence of the amplitude was fit to an equation 






























Figure S.2.3.6.  Concentration dependence of the amplitude for the slow phase binding of 
cis-3-chloroacrylic acid (50–4000 µM) to cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, 
pH 9.0, at 22 °C. The concentration dependence could not be fit. The reported 































Figure S.2.3.7.  Traces from 17 stopped-flow experiments in which E114Q-cis-CaaD (10 
µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of cis-3-
chloroacrylic acid (50-25,000 µM, top to bottom) at 22 °C.  The decrease in fluorescence 
was fit to either a single exponential (50-3,500 µM) or a double exponential (3,500-
25,000 µM).  The signal does not return to the initial fluorescence reading.  The reported 
concentrations are those after mixing enzyme and substrate.  The individual reactions 



























Figure S.2.3.8.  Seven representative traces from 17 stopped-flow experiments in which 
E114Q-cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal 
volume of cis-3-chloroacrylic acid (300 µM, 500 µM, 750 µM, 1500 µM, 5000 µM, 
15,000 µM, and 25,000 µM, top to bottom) at 22 °C.  The reported concentrations are 
those after mixing enzyme and substrate.  The individual reactions were monitored for 15 

























Figure S.2.3.9.  Concentration dependence of kobs for binding of cis-3-chloroacrylic acid 
(50–25,000 µM) to E114Q-cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 
°C.  The concentration dependence of the fast phase was fit to an equation for a 




























Figure S.2.3.10.  Concentration dependence of kobs for binding of cis-3-chloroacrylic acid 
(50–25,000 µM) to E114Q-cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 
°C.  The concentration dependence of the slow phase was fit to an equation for a 






























Figure S.2.3.11.  Concentration dependence of the amplitude for the fast phase binding of 
cis-3-chloroacrylic acid (50–25,000 µM) to E114Q-cis-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C.  The data could not be fit.  The reported 






























Figure S.2.3.12.  Traces from 13 stopped-flow experiments in which E114Q-cis-CaaD 
(10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of cis-3-
bromoacrylic acid (50-25,000 µM, top to bottom) at 22 °C.  The decrease in fluorescence 
was fit to a double exponential. The signals do not return to the initial fluorescence value. 
The reported concentrations are those after mixing enzyme and substrate.  The individual 





























Figure S.2.3.13.  Traces from 8 stopped-flow experiments in which E114Q-cis-CaaD (10 
µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of cis-3-
bromoacrylic acid (50 µM, 100 µM, 200 µM, 300 µM, 500 µM, 1500 µM, 5000 µM and 
15,000 µM, top to bottom) at 22 °C.  The decrease in fluorescence was fit to a double 
exponential.  The reported concentrations are those after mixing enzyme and substrate.  
The individual reactions were monitored for 15 s, showing that the signals do not return 


























Figure S.2.3.14.  Concentration dependence of kobs for binding of cis-3-bromoacrylic acid 
(50–25,000 µM) to E114Q-cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 
°C.  The concentration dependence of the fast phase was fit to an equation for a 





























Figure S.2.3.15.  Concentration dependence of kobs for binding of cis-3-bromoacrylic acid 
(50–25,000 µM) to E114Q-cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 
°C.  The concentration dependence of the slow phase was fit to an equation for a 





























Figure S.2.3.16.  Concentration dependence of the amplitude for the fast phase binding of 
cis-3-bromoacrylic acid (50–25,000 µM) to E114Q-cis-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C. The data could not be fit.  The reported concentrations 



























Figure S.2.3.17. Traces from 18 stopped-flow experiments in which P1A-cis-CaaD (10 
µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of cis-3-
chloroacrylic acid (12.5-25,000 µM, top to bottom) at 22 °C.  The reported 
concentrations are those after mixing enzyme and substrate. The data could not be fit.  

























Figure S.2.3.18.  Traces from 14 stopped-flow experiments in which P1A-cis-CaaD (10 
µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of cis-3-
chloroacrylic acid [12.5 µM (black), 25 µM (maroon), 50 µM (green), 100 µM (olive), 
200 µM (navy), 400 µM (purple), 500 µM (teal), 625 µM (red), 750 µM (lime), 1000 µM 
(yellow), 1500 µM (blue), 2500 µM (fuchsia), 3500 µM (aqua), and 5000 µM (pink)] at 
22 °C. The data could not be fit. The reported concentrations are those after mixing 


























Figure S.2.3.19.  Representative traces from 15 stopped-flow experiments in which P1A-
cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume 
of cis-3-bromoacrylic acid (12.5-25,000 µM, top to bottom) at 22 °C.  The reported 
concentrations are those after mixing enzyme and substrate. The data could not be fit. 

























Figure S.2.3.20.  Representative traces from 9 stopped-flow experiments in which P1A-
cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume 
of cis-3-bromoacrylic acid [12.5 µM (black), 50 µM (maroon), 100 µM (green), 300 µM 
(olive), 1500 µM (navy), 2500 µM (purple), 3500 µM (teal), 4500 µM (red), and 5000 
µM (lime)] at 22 °C.  The data could not be fit.  The reported concentrations are those 



























Figure S.2.3.21.  Traces from 12 stopped-flow experiments in which Y103F-cis-CaaD 
(10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of cis-3-
chloroacrylic acid (12.5-7,500 µM, top to bottom) at 22 °C.  The decrease in fluorescence 
was fit to a single exponential.  The reported concentrations are those after mixing 
enzyme and substrate.  The individual reactions were monitored for 2 s.  The signals do 



























Figure S.2.3.22.  Two representative traces from a total of 23 stopped-flow experiments 
in which Y103-cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an 
equal volume of cis-3-chloroacrylic (100 µM and 500 µM, top to bottom) at 22 °C.  The 
reported concentrations are those after mixing enzyme and substrate.  The individual 






























Figure S.2.3.23.  Concentration dependence of kobs for the fast phase binding of cis-3-
chloroacrylic acid (12.5–7,500 µM) to Y103F-cis-CaaD (10 µM) in 20 mM Na2HPO4 
buffer, pH 9.0, at 22 °C.  The data for 1400-7500 µM could not be fit.  The reported 





























Figure S.2.3.24.  Concentration dependence of kobs for binding of cis-3-chloroacrylic acid 
(12.5–1,400 µM) to Y103F-cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 
°C.  The concentration dependence of the fast phase up to 1400 µM was fit to an equation 



























Figure S.2.3.25.  Concentration dependence of the amplitude for the fast phase binding of 
cis-3-chloroacrylic acid (12.5–7,500 µM) to Y103F-cis-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C. The data from 1400-7500 µM could not be fit. The 





























Figure S.2.3.26.  Concentration dependence of the amplitude for the fast phase binding of 
cis-3-chloroacrylic acid (12.5–1,400 µM) to Y103F-cis-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C.  The concentration dependence of the amplitude for 





























Figure S.2.3.27.  Traces from 14 stopped-flow experiments in which Y103F-cis-CaaD 
(10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of cis-3-
bromoacrylic acid (12.5-7,500 µM, top to bottom) at 22 °C.  The decrease in fluorescence 
was fit to a single exponential. The signal does not return to the initial fluorescence 
reading. The reported concentrations are those after mixing enzyme and substrate.  The 































Figure S.2.3.28.  Two representative traces from a total of 21 stopped-flow experiments 
in which Y103-cis-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an 
equal volume of cis-3-bromoacrylic (25 µM and 100 µM, top to bottom) at 22 °C.  The 
reported concentrations are those after mixing enzyme and substrate.  The individual 
reactions were monitored for 10 s, showing that the signal does not return to the initial 





























Figure S.2.3.29.  Concentration dependence of kobs for the fast phase binding of cis-3-
bromoacrylic acid (12.5–7,500 µM) to Y103F-cis-CaaD (10 µM) in 20 mM Na2HPO4 
buffer, pH 9.0, at 22 °C.  The data from 1400-7500 µM could not be fit.  The reported 






























Figure S.2.3.30.  Concentration dependence of kobs for the fast phase binding of cis-3-
bromoacrylic acid (12.5–1,500 µM) to Y103F-cis-CaaD (10 µM) in 20 mM Na2HPO4 
buffer, pH 9.0, at 22 °C.  The concentration dependence of the fast phase up to 1400 µM 
was fit to an equation for a hyperbola.  The reported concentrations are those after mixing 

























Figure S.2.3.31.  Concentration dependence of the amplitude for the fast phase binding of 
cis-3-bromoacrylic acid (12.5–7,500 µM) to Y103-cis-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C.  The data for 1400-7500 µM could not be fit.  The 





























Figure S.2.3.32.  Concentration dependence of the amplitude for the fast phase binding of 
cis-3-bromoacrylic acid (12.5–1,500 µM) to Y103F-cis-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C.  The concentration dependence of the amplitude up to 
1400 µM was fit to an equation for a hyperbola.  The reported concentrations are those 

































Figure S.2.3.33.  Rapid quench experiment using 1000 µM E114Q-cis-CaaD with 25,000 
µM cis-3-bromoacrylic acid in 20 mM NaHCO3-NaOH buffer, pH 9.0, at 22 °C.  The 
reported concentrations are those after mixing enzyme and substrate.  The reaction shows 
a burst of bromide (24 ± 2 s-1) formation followed by a slow rate (56 ± 6 µM s-1) with an 












Table S.1.  Steady-State Kinetic Parameters for E114Q-cis-CaaD 
 
substrate      kcat    Km   kcat/Km 
       (s-1)   (µM)             (M-1 s-1) 
 
 
cis-3-Chloroacrylic Acida      .052 ± .001         30.6 ± 2.9         1.7 × 103 
 
cis-3-Bromoacrylic Acida      .056 ± .001         24.5 ± 4.0                2.3 × 103 
cis-3-Bromoacrylic Acidb              -c         -     - 
 
 
aThe steady-state kinetic parameters were determined in 20 mM sodium phosphate buffer 
(pH 9.0) at 22 °C.  Errors are standard deviations. 
 
bThe steady-state kinetic parameters were determined in 20 mM sodium bicarbonate 
buffer (pH 9.0) at 22 °C.  Errors are standard deviations. 
 













Table S.2.  Steady-State Kinetic Parameters for Y103F-cis-CaaD 
 
substrate      kcat    Km   kcat/Km 
       (s-1)   (µM)             (M-1 s-1) 
 
 
cis-3-Bromoacrylic Acida      0.31 ± 0.06         7.5 ± 0.8                4.1 × 104 
cis-3-Bromoacrylic Acidb        0.06 ± 0.01         13.7 ± 2.0               4.4 × 103 
 
 
aThe steady-state kinetic parameters were determined in 20 mM sodium phosphate buffer 
(pH 9.0) at 22 °C.  Errors are standard deviations. 
 
bThe steady-state kinetic parameters were determined in 20 mM sodium bicarbonate 


























Table S.3.  Pre-Steady State Kinetic Parameters Obtained for cis-CaaD and 





Enzyme           Kd a               krev a            kfor a                    Aob                      ∆Ab               Kd,appb     
           (µM)              (s-1)             (s-1)                                                 (µM) 
 
 
Wild type   1015 ± 210       31 ± 4        71 ± 3             0               3.1 ± 0.1         736 ± 120 
  
E114Q       2000 ± 200      0.3 ± 0.1    4.1 ± 0.1         n/a                  n/a                    n/a 
Y103F         250 ± 28        2.1 ± 0.2    7.9 ± 0.2           0               5.0 ± 0.1            93 ± 6      
 
 
aThe pre-steady state kinetic parameters were determined by non-linear regression 
analysis. The data (kobs vs [cis-3-chloroacrylic acid]) from stopped flow experiments were 
fit to an equation for a hyperbola:  rev
d
for







=  , where kobs is the rate of the 
fast phase fluorescence decrease, kfor is the forward reaction rate of the conformational 
change, krev is the reverse reaction rate of the conformational change, [S] is the 
concentration of substrate, and Kd is the binding constant.   Errors are standard 
deviations. 
 
bThe pre-steady state kinetic parameters were determined by non-linear regression 
analysis. The data (A vs [cis-3-chloroacrylic acid]) from stopped flow experiments were 
fit to an equation for a hyperbola:  o
appd,
 
 [S])  (
[S]  A
K
  AA +
+
∆
=  , where A is the amplitude of 
the fast phase fluorescence decrease, ∆A is the change in amplitude, Ao is the starting 








Table S.4.  Pre-Steady State Kinetic Parameters Obtained for cis-CaaD and 





Enzyme           Kd a               krev a            kfor a                    Aob                      ∆Ab               Kd,appb     
           (µM)              (s-1)             (s-1)                                                 (µM) 
 
 
Wild type   1400 ± 300       47 ± 3        89 ± 5             0               2.7 ± 0.1         690 ± 49 
  
E114Q       1817 ± 192             0          5.9 ± 0.2         n/a                  n/a                    n/a 
Y103F         108 ± 13               0          9.5 ± 0.2           0               4.9 ± 0.1            88 ± 11      
 
 
aThe pre-steady state kinetic parameters were determined by non-linear regression 
analysis. The data (kobs vs [cis-3-bromoacrylic acid]) from stopped flow experiments 
were fit to an equation for a hyperbola:  rev
d
for







=  , where kobs is the rate of 
the fast phase fluorescence decrease, kfor is the forward reaction rate of the 
conformational change, krev is the reverse reaction rate of the conformational change, [S] 
is the concentration of substrate, and Kd is the binding constant.   Errors are standard 
deviations. 
 
bThe pre-steady state kinetic parameters were determined by non-linear regression 
analysis. The data (A vs [cis-3-bromoacrylic acid]) from stopped flow experiments were 
fit to an equation for a hyperbola:  o
appd,
 
 [S])  (
[S]  A
K
  AA +
+
∆
=  , where A is the amplitude of 
the fast phase fluorescence decrease, ∆A is the change in amplitude, Ao is the starting 











Table S.5.  Pre-Steady State Kinetic Parameters Obtained for cis-CaaD and 





Enzyme           Kd a               krev a            kfor a                    Aob                      ∆Ab               Kd,appb     
           (µM)              (s-1)             (s-1)                                                 (µM) 
 
 
Wild type   130 ± 21       1.7 ± 0.1       1.5 ± 0.1         n/a                 n/a                     n/a 
  
E114Q      3660 ± 770           0             0.7 ± 0.1         n/a                  n/a                    n/a 
Y103F              n/a               n/a                  n/a            n/a                  n/a                    n/a 
 
 
aThe pre-steady state kinetic parameters were determined by non-linear regression 
analysis. The data (kobs vs [cis-3-chloroacrylic acid]) from stopped flow experiments were 
fit to an equation for a hyperbola:  rev
d
for







=  , where kobs is the rate of the 
slow phase fluorescence decrease, kfor is the forward reaction rate of the conformational 
change, krev is the reverse reaction rate of the conformational change, [S] is the 
concentration of substrate, and Kd is the binding constant.   Errors are standard 
deviations. 
 
bThe pre-steady state kinetic parameters were determined by non-linear regression 
analysis. The data (A vs [cis-3-chloroacrylic acid]) from stopped flow experiments were 
fit to an equation for a hyperbola:  o
appd,
 
 [S])  (
[S]  A
K
  AA +
+
∆
=  , where A is the amplitude of 
the slow phase fluorescence decrease, ∆A is the change in amplitude, Ao is the starting 












Table S.6.  Pre-Steady State Kinetic Parameters Obtained for cis-CaaD and 





Enzyme           Kd a               krev a            kfor a                    Aob                      ∆Ab               Kd,appb     
           (µM)              (s-1)             (s-1)                                                 (µM) 
 
 
Wild type   151 ± 21          1.9 ± 0.1      1.5 ± 0.1       n/a                  n/a                    n/a 
E114Q      7200 ± 820             0             2.2 ± 0.1       n/a                  n/a                    n/a 
Y103F              n/a                 n/a                 n/a           n/a                  n/a                    n/a 
 
 
aThe pre-steady state kinetic parameters were determined by non-linear regression 
analysis. The data (kobs vs [cis-3-bromoacrylic acid]) from stopped flow experiments 
were fit to an equation for a hyperbola:  rev
d
for







=  , where kobs is the rate of 
the slow phase fluorescence decrease, kfor is the forward reaction rate of the 
conformational change, krev is the reverse reaction rate of the conformational change, [S] 
is the concentration of substrate, and Kd is the binding constant.   Errors are standard 
deviations. 
 
bThe pre-steady state kinetic parameters were determined by non-linear regression 
analysis. The data (A vs [cis-3-bromoacrylic acid]) from stopped flow experiments were 
fit to an equation for a hyperbola:  o
appd,
 
 [S])  (
[S]  A
K
  AA +
+
∆
=  , where A is the  amplitude of 
the slow phase fluorescence decrease, ∆A is the change in amplitude, Ao is the starting 












Chapter 3:  A Pre-steady State Kinetic Analysis of trans-3-Chloroacrylic 




3.1 Introduction   
  trans-3-Chloroacrylic acid dehalogenase (CaaD) catalyzes the hydrolytic 
dehalogenation of trans-3-haloacrylates (e.g., trans-3-chloro- and 3-bromoacrylate,  2 
and 3, respectively in Scheme 1) to afford malonate semialdehyde (4) and the 
corresponding hydrohalic acid (1,2).  The CaaD-catalyzed reaction (using 2) represents 
one step in the bacterial catabolism of the nematocide, 1,3-dichloropropene (1, Scheme 1) 
in various soil organisms such as Pseudomonas pavonaceae 170 and coryneform 
bacterium strain FG41 (3).  Although CaaD was first identified and partially purified in 














3    
 
  CaaD is a heterohexamer composed of 3 α-subunits and 3 β-subunits (4).  The 
small size of these subunits (70 and 75 amino acids, respectively) and sequence analysis 
initially placed CaaD in the tautomerase supeerfamily (1), a group of structurally 
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homologous proteins characterized by a common β−α−β building block and a catalytic 
amino-terminal proline (6-8).  Subsequently, mechanistic, inhibition, mutagenesis, 
crystallographic, and NMR studies elucidated key details of the enzyme-catalyzed 
reaction, resulting in the current working hypothesis for the mechanism shown in Scheme 
2 (1,2,4,5).  In the proposed mechanism, αGlu-52 activates water for attack at C-3 of 2 or 
3 by abstraction of a hydrogen.  A pair of arginines (αArg-8 and αArg-11) concomitantly 
interacts with the C-1 carboxylate group to bind and polarize the substrate for attack.  The 
CaaD-catalyzed addition of water to the double bond of 2 (or 3) is completed by 
protonation at C-2, which is effected by βPro-1, functioning as a general acid catalyst.    
  Our understanding of the CaaD mechanism is still rudimentary.  For example, it is 
not known if the reaction proceeds through a halohydrin intermediate (e.g., 5, Scheme 2) 
or an enol intermediate (e.g., 6, Scheme 2) (4,8).  In addition to the mechanistic 
significance, a determination of which intermediate is operative has evolutionary 
implications.  The presence of the halohydrin intermediate could suggest that CaaD is an 
“accidental” dehalogenase.  The enzyme may be a physiological hydratase that catalyzes 
the addition of water across the double bonds of unknown α,β-unsaturated acids (4,8).   
In the case of 2 or 3, this reaction generates a halohydrin intermediate that undergoes 
rapid decay to 4.  The formation of 6 in the reaction, and the presence of a halide binding 



















































  As part of an effort to understand the mechanism of CaaD more completely, a 
pre-steady state kinetic analysis of the reaction was initiated.  For this analysis, it was 
necessary to construct a mutant of CaaD where αPhe-39, a residue located in the active 
site (4), was replaced with a tryptophan residue.  The resulting αF39W mutant introduces 
the only fluorophore in the enzyme.  A series of stopped flow experiments was then 
carried out on the enzyme using 2 and 3.  For both, there is a decrease in fluorescence 
that can be fit to a double exponential. The fluorescence signal does not return to its 
initial value.  Analysis of the double exponential for 2 yields the apparent Kd for substrate 
binding. It was not possible to analyze the rate constants from the double exponential 
observed for 3. The completion of these studies, the formulation of a kinetic model, and a 
comparison of the results to those obtained for various mutants will provide more insight 
into the individual steps in the CaaD-catalyzed reaction and how mutations impact these 
steps.  Finally, a comparison of this analysis with that carried out on cis-3-chloroacrylic 
acid dehalogenase, which is in a different family in the tautomerase superfamily (9), will 
underscore similarities and differences between these two enzymes.     
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3.2 Materials and Methods 
  Materials.  All reagents, buffers, and solvents were obtained from Sigma Aldrich 
Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Pittsburgh, PA), Spectrum 
Laboratory Products, Inc. (New Brunswick, NJ), or EM Science (Cincinnati, OH), unless 
noted otherwise. Pre-packed PD-10 Sephadex G-25 columns were purchased from 
Biosciences AB (Uppsala, Sweden).  E. coli BL21-Gold(DE3) cells were purchased from 
Stratagene (La Jolla, CA). The components of LB, SOB, and SOC medium were obtained 
from sources reported elsewhere (2,10).  
  General Methods.  Protein was analyzed by SDS-PAGE under denaturing 
conditions on gels containing 15% polyacrylamide (11).  The gels were stained with 
Coomassie brilliant blue.  Protein concentrations were determined by the method of 
Waddell (12).  Absorbance data were obtained on a Hewlett Packard 8452A Diode Array 
spectrophotometer.  The steady-state kinetic data were fitted by nonlinear regression data 
analysis using the Grafit program (Erithacus Software Ltd., Horley, U.K.) obtained from 
Sigma Chemical Co.  The pre-steady state kinetic data were fit and simulated using 
KinTekSim (Austin, TX). The stopped flow experiments were carried out on a SF 2004 
series stopped flow apparatus from Kintek Corp. (Austin, TX).   
Composition of SOB and SOC Media.  The SOB medium was made by mixing 
tryptone (4 g) and yeast extract (1 g) in 100 mL of deionized water (10).  The mixture 
was then autoclaved for 45 min and stored in a sealed glass bottle at 22 °C until ready to 
use.  The SOC medium (10 mL) was made by mixing 4.7 mL of deionized water with 
SOB medium (5 mL).  To this mixture, MgSO4 (0.1 mL of a 1 mg/mL stock solution), 
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NaCl/KCl (0.1 mL of a 1 mg/mL stock solution), and glucose (0.1 mL of a 1 mg/mL 
stock solution) were added (10).  The solution was mixed at 22 °C and used immediately 
after being made.   
3.2.1 Transformation, Expression, and Purification of CaaD and the αF39W 
Mutant 
 
Transformation of Expression Cells for CaaD.  E. coli BL21-Gold(DE3) 
competent cells were thawed and stored on ice.  Competent cells (~100 µL) were pipetted 
into a pre-chilled 15-mL Falcon 2059 tube along with the expression vector for CaaD, 
designated pET 44T2 (~50 ng) (1).   The reaction mixture was gently incubated on ice for 
30 min.  During this time, a 900-µL aliquot of SOC medium was preheated in a water 
bath to 42 °C.  The reaction mixture was heat-pulsed for 20 s in a water bath at 42 °C and 
then incubated on ice for 2 min.  Subsequently, the 900-µL aliquot of SOC medium was 
added to the reaction mixture.  The cells were incubated at 37 °C for 1 h in an 
environmental shaker at 225 rpm. The cells were then concentrated by centrifugation 
(500 rpm for 5 min), and a 600-µL portion of the supernatant was removed.  The cells 
were resuspended in the remaining supernatant.  A portion of the resulting transformation 
reaction mixture (200 µL) was plated, using a sterile spreader, onto two LB/Ap (50 
µg/mL) agar plates.  The plates were then incubated overnight (~ 16 h) at 37 °C.   
Overexpression and Purification of CaaD.  Wild-type CaaD was produced in E. 
coli BL21-Gold(DE3) cells using the T7 expression system (1).  The freshly transformed 
cells, with the plasmid containing the genes for the α- and β- subunit of CaaD (1), were 
collected from a plate and used to inoculate three 2-liter flasks containing 1L of LB/Ap 
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(100 mg/L).  After overnight growth at 30 °C in an environmental shaker at 225 rpm, 
cells were harvested by centrifugation (15 min at 7,000 rpm) and stored at -20 °C until 
further use.  Typically, 1 L of culture yields 7 g of cells. 
Cells (~21 g) were thawed and suspended in 11 mL of 10 mM Tris-SO4 buffer, 
pH 8.0, and placed on ice.  Cells were disrupted, while stirring on ice, by sonication at 60 
W output (in a W385 sonicator of Heat Systems-Ultrasonics, Inc.) for ten 2-min intervals 
using 5-s pulses with a cycle time of 50%.  After each 2-min interval, cells were allowed 
to sit for 5 min. DNase (10 µL of a 10 Units/µL solution) and RNase (10 mL of a 500 
µg/mL solution) were added to the solution and allowed to stir on ice for 1 h.  The lysed 
cells were then centrifuged at 17,000 rpm for 45 min. The supernatant was retained and 
centrifuged at 60,000 rpm for 1 h (1,2).  
 Subsequently, the supernatant was filtered through a 0.2 µm-pore diameter filter 
and applied to a TSKgel DEAE-5PW anion-exchange column (150 × 21.5 mm), which 
had been previously equilibrated with 10 mM Tris-SO4 buffer, pH 8.0.  The column was 
washed with 10 mM Tris-SO4 buffer, pH 8.0, containing 0.5 M Na2SO4 for 20 min and 
the protein was eluted using a linear gradient (0-0.5 M Na2SO4) at a flow rate of 5 
mL/min over a 90 min period.  Fractions were collected at 1.75 min intervals (8.75 mL). 
Fractions (#4-14) with the highest purity (as determined by SDS PAGE) were pooled and 
concentrated to ~16 mL using an Amicon stirred cell equipped with an YM10 (10,000 
MW cutoff) ultrafiltration membrane (1,2).   
Solid (NH4)2SO4 was added to the concentrate to make a final concentration of 
1.6 M and the resulting solution was stirred for 1 h at 4 °C.  The solution was centrifuged 
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at 11,000 rpm for 15 min and the supernatant was filtered through a 0.2 µm-pore 
diameter filter and applied to a TSKgel Phenyl-5PW column (150 × 21.5 mm) which had 
been previously equilibrated with 10 mM Tris-SO4 buffer, pH 8.0, containing 1.0 M 
(NH4)2SO4. The protein was eluted with a decreasing linear gradient [1.0 to 0 M 
(NH4)2SO4] at a flow rate of 5 mL/min.  Fractions were collected at 1.75 min intervals 
(8.75 mL) over a 90-min period.  The fractions (#10-16) with the highest purity (as 
determined by SDS-PAGE) were concentrated to ~6 mL using an Amicon stirred cell 
equipped with an YM10 (10,000 MW cutoff) ultrafiltration membrane and stored at 4 °C.  
This purification resulted in ~120 mg of 95% pure as assessed by ESI mass spectroscopy 
protein (α-subunit MW 8,342, β-subunit MW 7,505) and SDS-PAGE.  
Expression and Purification of the αF39W Mutant of CaaD.  The plasmid 
containing the αF39W mutant of CaaD was transformed as described for the wild type 
CaaD gene into E. coli BL21-Gold(DE3) cells for protein expression.  The plasmid was 
constructed by Dr. Linette Watkins.  The gene product was expressed using the T7 
expression system as described for wild type.  Typically, 1 L of culture yields 7 g of cells 
which were frozen until ready for use.  The cells (~21 g) were thawed and processed 
following the protocol described for lysis of wild type cells and subsequent protein 
purification. Fractions (#6-22) from the TSKgel DEAE-5PW anion-exchange column 
with the higest purity (as determined by SDS-PAGE) were pooled and concentrated to 
~16 mL using an Amicon stirred cell equipped with an YM10 (10,000 MW cutoff) 
ultrafiltration membrane.  Fractions (#19-20) from the TSKgel Phenyl-5PW column with 
the highest purity (as determined by SDS-PAGE) and activity (as determined by an 
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activity assay) were concentrated to ~6 mL using an Amicon equipped with an YM10 
(10,000 MW cutoff) ultrafiltration membrane and stored at 4 °C.  This purification 
resulted in ~100 mg of 95% pure protein as assessed by ESI mass spectroscopy (α-
subunit MW 8,381, β-subunit MW 7,505) and SDS-PAGE.  
3.2.2 Activity Assay for αF39W-CaaD 
 Activity Assay for αF39W-CaaD.  A sample of protein (20 µL) from each fraction 
was placed in a cuvette containing 1 mL of 20 mM Na2HPO4 buffer, pH 9.0.  The 
solution was gently mixed and allowed to sit at 22 °C for 30 min. Subsequently, the 
sample was used to blank the spectrophotometer at 224 nm.  A 4-µL aliquot of 50 mM 
trans-3-chloroacrylic acid in 20 mM Na2HPO4 buffer, pH 9.0, was then added and the 
absorbance decrease was monitored at 224 nm (2).  Absorbance readings were recorded 
every min for a 5 min period. Fractions showing the largest change in absorbance were 
collected and concentrated. 
3.2.3 Steady-State Kinetic Parameters for CaaD 
The Steady-State Kinetic Parameters for CaaD.  The steady-state parameters for 
CaaD were measured using trans-3-chloro- and trans-3-bromoacrylic acid.  The assays 
were carried out at 22 °C in 20 mM Na2HPO4 buffer, pH 9.0 (2).  A 25 mL solution of 
CaaD (2 µM based on monomeric mass) was made up in buffer and allowed to 
equilibrate at 22 °C for 1 h.  The assay was initiated by the addition of trans-3-chloro- or 
trans-3-bromoacrylic acid (10 µM - 500 µM) from a 10 mM or 50 mM stock solution (in 
100 mM Na2HPO4 buffer, pH 9.0). The addition of substrate to a 100 mM Na2HPO4 
buffer, pH 9.0, adjusted the pH of the stock solution from 9.0 to a final pH of 7.3. The 10 
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mM stock solution was made by diluting an aliquot of the 50 mM stock solution into 100 
mM Na2HPO4 buffer, pH 7.3.  The decrease in absorbance at 224 nm, corresponding to 
the hydration of trans-3-chloroacrylate (ε = 4900 M-1 cm-1) (2) or trans-3-bromoacrylate 
(ε = 9700 M-1 cm-1) (2), was monitored over a 60-s time interval, recording readings 
every 1.5 s.  The rates of substrate depletion over the first 40 s were then plotted versus 
the corresponding substrate concentrations.  The hyperbolic curve was fit by nonlinear 
regression analysis to the Michaelis-Menten equation, provided in the Grafit program 
(Erithacus Software Ltd., Horley, U.K.) to determine the values of kcat and Km.   
3.2.4 Steady-State Parameters for the αF39W Mutant of CaaD 
Steady-State Kinetic Parameters for αF39W-CaaD.  The steady-state kinetic 
parameters for αF39W-CaaD were measured using trans-3-chloro- and trans-3-
bromoacrylic acid.  The assays were carried out at 22 °C in 20 mM Na2HPO4 buffer, pH 
9.0.  A 25 mL solution of αF39W-CaaD (2 µM based on monomeric mass) was made up 
in buffer and allowed to equilibrate at 22 °C for 1 h.  The assay was initiated by the 
addition of trans-3-chloro- or trans-3-bromoacrylic acid (5 µM – 400 µM) which were 
made from 10 mM or 50 mM stock solutions (in 100 mM Na2HPO4 buffer, pH 9.0). The 
addition of substrate to a 100 mM Na2HPO4 buffer, pH 9.0, adjusted the pH of the stock 
solution from 9.0 to a final pH of 7.3. The 10 mM stock solution was made by diluting an 
aliquot of the 50 mM stock solution into 100 mM Na2HPO4 buffer, pH 7.3.  The decrease 
in absorbance at 224 nm, corresponding to the hydration of trans-3-chloroacrylate (ε = 
4900 M-1 cm-1) (2) or trans-3-bromoacrylate (ε = 9700 M-1 cm-1) (2) was monitored over 
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a 60-s time interval, recording readings every 1.5 s.  The rates of substrate depletion over 
the first 30 s were then plotted versus the corresponding substrate concentrations.  The 
hyperbolic curve was fit by nonlinear regression analysis to the Michaelis-Menten 
equation, provided in the Grafit program (Erithacus Software Ltd., Horley, U.K.) to 
determine the values of kcat and Km. 
3.2.5 Stopped Flow Experiments Using αF39W-CaaD  
 
Stopped Flow Experiments Using αF39W-CaaD.  All stopped flow experiments 
and measurements were carried out using a SF 2004 series stopped flow apparatus from 
Kintek Corp. (http://www.kintek-corp.com). αF39W-CaaD (20 µM based on monomer 
molecular mass)  was made up in 20 mM Na2HPO4 buffer, pH 9.0, and allowed to 
equilibrate at 22 °C for 1 h.  Various concentrations of trans-3-chloro- or trans-3-
bromoacrylic acid (50-50,000 µM before mixing) were made up in 100 mM Na2HPO4 
buffer, pH 9.0. The addition of trans-3-chloro- or trans-3-bromoacrylic acid to the buffer 
adjusted the pH to ~7.8. The enzyme (10 µM after mixing) and substrate (25-25,000 µM 
after mixing) solutions were then mixed in the stopped flow apparatus at 22 °C. The pH 
after mixing was 7.8.  The samples were excited at 280 nm and fluorescence emission 
was monitored using a photomultiplier tube equipped with a 340 nm long pass Corion 
filter.  In order to reduce photobleaching, the slit width on the xenon light source and the 
light filter were set at 3.16 mm. The high voltage output was set at 717 volts. Three time 
courses (0.2 s, 2.5 s, and 10 s) consisting of five runs per time course were recorded for 
each substrate concentration.  Rate constants were obtained by analyzing the fluorescence 
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signals collected in the stopped-flow experiments by non-linear regression. (The traces 
for the 0.2 time course are not shown.) 
3.3 Results 
3.3.1 Steady-State Parameters for CaaD and αF39W-CaaD 
Steady-State Kinetic Parameters for CaaD and the αF39W mutant of CaaD.   The 
steady state kinetic parameters for CaaD and the αF39W mutant using trans-3-chloro or 
trans-3-bromoacrylate were measured in 20 mM Na2HPO4 buffer, pH 9.0 (2). The results 
of these experiments provide the necessary background for pre-steady state kinetic 
analysis experiments.  The values of Km and kcat (Table 1) for CaaD with trans-3-chloro- 
and trans-3-bromoacrylic acid differ from those of αF39W-CaaD but not significantly 
(Table 2).  For αF39W-CaaD with trans-3-chloroacrylate, the values of Km and kcat 
showed a 4.8-fold increase and a 5.2-fold decrease, respectively, when compared to wild 
type CaaD.  This resulted in a 2.6-fold decrease in the value of kcat/Km.  For cis-3-
bromoacrylate the values of Km and kcat showed a 5-fold increase and a 5.5-fold decrease, 
respectively.  This resulted in a 2.7-fold decrease in the value of kcat/Km.  The kinetic 









Table 1.  Steady-State Kinetic Parameters for CaaD 
 
substrate      kcat    Km   kcat/Km 
       (s-1)   (µM)             (M-1 s-1) 
 
 
trans-3-Chloroacrylic Acida      2.2 ± 0.1         21 ± 1                  1.1 × 104 
 
trans-3-Bromoacrylic Acida      2.4 ± 0.1         20 ± 2                1.2 × 104 
 
 
aThe steady-state kinetic parameters were determined in 20 mM sodium phosphate buffer 





Table 2.  Steady-State Kinetic Parameters for αF39W-CaaD 
 
substrate      kcat    Km   kcat/Km 
       (s-1)   (µM)             (M-1 s-1) 
 
 
trans-3-Chloroacrylic Acida      0.42 ± .01         100 ± 2                  4.2 × 103 
 
trans-3-Bromoacrylic Acida      0.44 ± .01         100 ± 2                4.4 × 103 
 
 
aThe steady-state kinetic parameters were determined in 20 mM sodium phosphate buffer 







3.3.2 Stopped Flow Kinetic Experiments Using αF39W-CaaD  
 
In order to examine the ground-state binding of CaaD with trans-3-chloro- and 
trans-3-bromoacrylic acid by stopped flow fluorescence, it was first necessary to 
introduce a fluorophore into CaaD.  αPhe-39 was selected for site-specific mutagenesis 
because the available crystal structure showed that it was in the active site (3). Hence, 
αPhe-39 was mutated to αTrp-39, therefore introducing a fluorophore that can monitor 
events at the active site such as a conformational change of the enzyme upon substrate 
binding and/or chemistry.  The αF39W mutant of CaaD was used in subsequent stopped 
flow experiments where the enzyme was mixed with trans-3-chloro- or trans-3-
bromoacrylic acid.  A series of decreasing fluorescent signals was collected, using a 
stopped-flow apparatus, at increasing concentrations of trans-3-chloro- or trans-3-
bromoacrylic acid (Figures 3.1-3.2 and Figures 3.3-3.4, respectively).  The stopped-flow 
traces were analyzed using non-linear regression and fit to a double exponential equation 
to yield rates (kobs) and amplitudes for the fast and slow phases (15).  The observed rate 
constants were then plotted versus the corresponding trans-3-chloroacrylic acid 
concentrations (Figures 3.5-3.8) and resulting curve was fit to a hyperbola (equation 1),    
kobs =    kmax × [S]         (1) 
             Kd + [S]   
  
where kobs is the observed rate, kmax is the maximum observed rate, [S] is substrate 
concentration, and Kd is the ground-state binding constant.  The resulting curves for the 
fast phase and slow phase are shown in Figures 3.5 and 3.6.  The non-linear regression 
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analysis suggests weak ground state binding of substrate where Kd is 3500 ± 400 µM, 
followed by a second step with a kmax of 13.5 ± 0.4 s-1 (Figure 3.5) (15).   
The stopped-flow fluorescence traces for αF39W-CaaD with trans-3-
bromoacrylic acid were also fit to a double exponential and the kobs values were plotted 
against the corresponding substrate concentrations (Figures 3.9-3.12).  However, the 
concentration dependence of the kobs and the amplitude for the fast phase and the 
concentration dependence of the amplitude for the slow phase could not be fit.  The 
concentration dependence of kobs for the slow phase could be fit to the equation for a 
hyperbola.  The resulting Kd was 2500 ± 2000 µM (Figure 3.10).  The magnitude of the 


























Figure 3.1.  Traces from 19 stopped-flow experiments in which αF39W-CaaD (10 µM) 
in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of trans-3-
chloroacrylic acid (25-11,000 µM, top to bottom) at 22 °C.  The decrease in fluorescence 
was fit to a double exponential.  The reported concentrations are those after mixing 


























Figure 3.2.  Three representative traces from a total of 19 stopped-flow experiments  in 
which αF39W-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an 
equal volume of trans-3-chloroacrylic acid (2000 µM, 3000 µM, and 4000 µM, top to 
bottom) at 22 °C.  The data were fit to a double exponential and the rates are 4.79 ± 0.01 
s-1 (k1) and 0.824 ± 0.001 s-1 (k2); 6.31 ± 0.01 s-1 (k1) and 0.887 ± 0.001 s-1 (k2); 7.27 ± 
0.01 s-1 (k1)  and 0.875 ± 0.011 s-1 (k2), respectively.  The reported concentrations are 
those after mixing enzyme and substrate.  The reactions were monitored for 10 s but only 




















Figure 3.3.  Traces from 16 stopped-flow experiments in which αF39W-CaaD (10 µM) 
in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an equal volume of trans-3-
bromoacrylic acid (150-25,000 µM, top to bottom) at 22 °C.  The decrease in 
fluorescence was fit to a double exponential.  The reported concentrations are those after 






















Figure 3.4.  Three representative traces from a total of 16 stopped-flow experiments in 
which αF39W-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, was mixed with an 
equal volume of trans-3-bromoacrylic acid (2000 µM, 3000 µM, and 4000 µM, top to 
bottom) at 22 °C.  The data was fit to a double exponential and their rates are 10.39 ± 
0.01 s-1 (k1) and 1.591 ± 0.001 s-1 (k2); 5.92 ± 0.01 s-1 (k1) and 1.747 ± 0.001 s-1 (k2); 41.9 
± 5.1 s-1 (k1)  and 1.957 ± 0.001 s-1 (k2), respectively.  The reported concentrations are 





















Figure 3.5.  Concentration dependence of kobs for binding of trans-3-chloroacrylic acid 
(25–11,000 µM) to αF39W-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 °C.  
The concentration dependence of the fast phase was fit to a hyperbolic equation using 
non-linear regression to derive a ground-state binding constant (Kd) of 3500 ± 400 µM 
and a maximum rate of 13.4 ± 0.4 s-1 for a subsequent step.  The reported concentrations 






















Figure 3.6.  Concentration dependence of kobs for binding of trans-3-chloroacrylic acid 
(25–11,000 µM) to αF39W-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 °C.  
The concentration dependence of the slow phase was fit to a hyperbolic equation using 
non-linear regression analysis to derive a maximum rate of 0.90 ± 0.10 s-1.  The reported 






















Figure 3.7.  Concentration dependence of the amplitude for the fast phase binding of 
trans-3-chloroacrylic acid (25–11,000 µM) to αF39W-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C. The data could not be fit. The reported concentrations 





















Figure 3.8.  Concentration dependence of the amplitude for the slow phase binding of 
trans-3-chloroacrylic acid (25–11,000 µM) to αF39W-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C.  The data could not be fit.  The reported 





















Figure 3.9.  Concentration dependence of kobs for binding of trans-3-bromoacrylic acid 
(150–25,000 µM) to αF39W-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 
°C.  The concentration dependence of the fast phase could not be fit.  The reported 
























Figure 3.10.  Concentration dependence of kobs for binding of trans-3-bromoacrylic acid 
(150–25,000 µM) to αF39W-CaaD (10 µM) in 20 mM Na2HPO4 buffer, pH 9.0, at 22 
°C.  The concentration dependence of the slow phase could be fit to an equation for a 
hyperbola, but the errors were significant.  The reported concentrations are those after 
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Figure 3.11.  Concentration dependence of the amplitude for the fast phase binding of 
trans-3-bromoacrylic acid (150–25,000 µM) to αF39W-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C. The concentration dependence of the amplitude for the 
fast phase could not be fit. The reported concentrations are those after mixing enzyme 





















Figure 3.12.  Concentration dependence of the amplitude for the slow phase binding of 
trans-3-bromoacrylic acid (150–25,000 µM) to αF39W-CaaD (10 µM) in 20 mM 
Na2HPO4 buffer, pH 9.0, at 22 °C.  The concentration dependence of the amplitude for 
the slow phase could not be fit. The reported concentrations are those after mixing 
enzyme and substrate.   
 
3.4 Discussion 
 CaaD and cis-CaaD carry out hydrolytic dehalogenation reactions on the 
respective isomers of 3-chloro- and 3-bromoacrylate (1, 2, 9).  Although initial studies 
indicated that the mechanisms of the two enzymes largely paralleled one another with 
subtle differences (9), subsequent crystallographic (13) and inhibition studies (14) 
revealed more significant differences.  In order to better understand the mechanism of 
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both enzymes and to determine whether the observed differences had a basis in the 
microscopic rate constants, a pre-steady state kinetic analysis was initiated. 
 For cis-CaaD, stopped-flow and rapid quench chemical quench experiments 
provided a five-step minimal kinetic model for the mechanism.  A similar strategy is 
being pursued for CaaD.  Thus far, only stopped-flow experiments have been carried out.   
Unlike cis-CaaD, however, CaaD does not have a fluorophore.  For this reason, a mutant 
of CaaD was made where αPhe-39, a residue located in the active site (4), was replaced 
with a tryptophan residue.  The resulting αF39W mutant introduces the only fluorophore 
in the enzyme.  The mutant retains significant dehalogenase activity (~20 % of wild 
type), and the fluorescence signal was sufficient for kinetic studies. 
 Stopped-flow experiments were carried out on αF39W-CaaD using two 
substrates, trans-3-chloro- and trans-3-bromoacrylic acid.  Both of these substrates, when 
mixed with αF39W-CaaD, produced a decrease in fluorescence signal which could be fit 
to an equation for a double exponential.  The observed rates for both the fast decrease in 
fluorescence and the slow decrease in fluorescence using trans-3-chloroacrylic acid could 
be fit to a hyperbola and analyzed using non-linear regression.  This analysis gave a weak 
ground state binding constant of 3500 ± 500 µM and a maximum rate of 13.4 ± 0.4 s-1.   
 The data for the decrease in fluorescence signal observed for αF39W-CaaD and 
trans-3-bromoacrylic acid could also be fit to a double exponential, but the resulting plots 
versus substrate concentrations could not be fit.  It is not clear why the data cannot be fit 
but it may be related to the size of the bromide coupled with the introduction of the larger 
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 In the absence of additional experiments, the stopped-flow data for trans-3-
chloroarylic acid was simulated and fit to a two-step binding mechanism followed by 
chemistry (Scheme 3).  A comparison of the Kd value obtained for cis-CaaD (~1400 µM) 
versus CaaD (~3500 µM) shows stronger binding for the cis-CaaD substrate.  There are 
(at least) two explanations for this observation.  The first one is that substrate binds 
comparably to both wild type enzymes but the larger side chain of the tryptophan in the 
αF39W mutant weakens binding.  The second explanation is based on the fact that cis-
CaaD has two additional groups, His-28 and Tyr-103, at the active site (13).  The 
presence of these residues, particularly His-28, may give rise to stronger binding of cis-3-
chloroacrylate.  Stronger binding, may also reflect the importance of substrate activation 
to the cis-CaaD mechanism.  The latter explanation is highly speculative but tantalizing.  
Additional evidence may be provided by the planned pre-steady state kinetic analysis of 
cis-CaaD mutants.  Completion of the pre-steady state kinetic analysis of CaaD may 
uncover how individual rate constants correlate with with observed catalytic properties. 
 Another goal of this study was to determine the feasibility of pre-steady state 
kinetic experiments and to identify conditions under which these experiments could be 
conducted.  It is apparent that using the trans-3-bromoacrylic acid with αF39W-CaaD in 
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20 mM Na2HPO4 buffer does not produce data that are subject to analysis.  It may be 
possible to circumvent this problem by changing to Tris or NaHCO3 buffers.  If these 
buffers do not produce reliable data, then it will be necessary to develop an ion 
chromatography method for quantification of chloride ion and use cis-3-chloroacrylic 
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Chapter 4:   Inactivation of Cg10062, a Tautomerase Superfamily 
Member from Corynebacterium glutamicum by (R)- and (S)-Oxirane-2-
carboxylate:  Analysis and Implications 
 
  
4.1  Introduction  
  Cg10062 is a cis-3-chloroacrylic acid dehalogenase (cis-CaaD) homologue (~34% 
sequence similarity) found in Corynebacterium glutamicum (1). The physiological role 
and reaction of Cg10062 are unknown and the gene has no clear genomic context.  In 
contrast, cis-CaaD catalyzes the conversion of cis-3-chloroacrylic acid (2, Scheme 1) to 
malonate semialdehyde (4), which is one of the reactions in a catabolic pathway for the 
nematocide 1,3-dichloropropene (1) in coryneform bacterial strain FG41 (2,3).  An 
enzyme-catalyzed-decarboxylation of 4 completes the overall transformation of 1 to 
acetaldehyde (5).  cis-CaaD, and its counterpart in Pseudomonas pavonaceae 170, trans-
3-chloroacrylic acid dehalogenase (CaaD), which processes 3 to 4, are highly specific for 
their substrates (4,5).  Cg10062 is not isomer-specific and exhibits low level cis-CaaD 



























  Both Cg10062 and cis-CaaD are trimers composed of 149-amino acid monomers, 
and a sequence comparison shows that six key catalytic residues (Pro-1, His-28, Arg-70, 
Arg-73, Tyr-103, and Glu-114) in cis-CaaD are present in Cg10062 (1,6,7).  In the 
proposed cis-CaaD mechanism, Glu-114 and Tyr-103 activate a water molecule for 
addition to C-3 of 2 (1,7).  His-28, Arg-70, and Arg-73 interact with the C-1 carboxylate 
group to bind and “activate” the substrate for the conjugate addition of water (1,7).  Pro-1 
provides a proton to C-2, which completes the reaction and yields 4.  The sum of these 
observations suggests that subtle active site differences may account for the diminished 
dehalogenase activity of Cg10062 and the less stringent substrate specificity.   
  As part of an effort to delineate these differences, we examined (R)- and (S)-
oxirane-2-carboxylate (6) as potential irreversible inhibitors of Cg10062.  We have 
previously reported that cis-CaaD is irreversibly inactivated by (R)-6, due to the covalent 
modification of Pro-1 (8).  The (S)-enantiomer is not an irreversible inhibitor and neither 
enantiomer inactivates CaaD.  In accord with the relaxed substrate specificity and 
preference for 2, we find that Cg10062 is irreversibly inactivated by both enantiomers, 
with the (R)-enantiomer being more potent.  Inactivation is due to covalent modification 
of Pro-1.  Pro-1, Arg-70, and Arg-73 are essential for the inactivation of Cg10062, 
whereas Glu-114 may play a role but not an essential one.  These observations parallel 
those found for cis-CaaD but the lack of stereospecificity and the participation of Glu-
114 distinguish the inactivation mechanism for Cg10062 from that of cis-CaaD.  Hence, 
the inactivation mechanisms will likely be similar, but may result from different 
orientations in the active site.  These results provide the necessary foundation for a 
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crystallographic analysis of Cg10062 inactivated by (R)- and (S)-6 so that these 
orientations can be determined.   
 




4.2 Materials and Methods 
  Materials.  All reagents, buffers, and solvents were obtained from Sigma Aldrich 
Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Pittsburgh, PA), Spectrum 
Laboratory Products, Inc. (New Brunswick, NJ), or EM Science (Cincinnati, OH), unless 
noted otherwise.  Literature procedures were used for the syntheses of (R)- and (S)-6 (9) 
and 2-oxo-3-pentynoate (7) (10).  cis-CaaD, malonate semialdehyde decarboxylase 
(MSAD), Cg10062, and the Cg10062 mutants (P1A, R70A, R73A, and E114Q) (6) were 
purified to homogeneity, as assessed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE), by variations of published procedures (1,6,11).  The 
construction and characterization of the Cg10062 mutants are reported elsewhere (6).  
Pre-packed PD-10 Sephadex G-25 columns were purchased from Biosciences AB 
(Uppsala, Sweden).  Endoproteinase Glu-C (protease V-8) was obtained from F. 
Hoffmann-La Roche, Ltd. (Basel, Switzerland).   
Composition of SOB and SOC Media.  The SOB medium was made by mixing 
tryptone (4 g) and yeast extract (1 g) in 100 mL of deionized water.  The mixture was 
then autoclaved for 45 min and stored in a sealed glass bottle at 22 °C until ready to use.  
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The SOC medium (10 mL) was made by mixing 4.7 mL of deionized water with SOB 
medium (5 mL).  To this mixture, MgSO4 (0.1 mL of a 1 mg/mL stock solution), 
NaCl/KCl (0.1 mL of a 1 mg/mL stock solution), and glucose (0.1 mL of a 1 mg/mL 
stock solution) were added.  The solution was mixed at 22 °C and used immediately after 
being made.   
  General Methods.  Protein was analyzed by SDS-PAGE under denaturing 
conditions on gels containing 15% polyacrylamide (12).  The gels were stained with 
Coomassie brilliant blue.  Protein concentrations were determined by the method of 
Waddell (13).  Absorbance data were obtained on a Hewlett Packard 8452A Diode Array 
spectrophotometer.  The kinetic data were fitted by nonlinear regression data analysis 
using the Grafit program (Erithacus Software Ltd., Horley, U.K.) obtained from Sigma 
Chemical Co.  Cg10062 activity was determined by following the absorbance increase at 
296 nm (ε = 7000 M-1 cm-1), which corresponds to formation of acetopyruvate (8) by the 
Cg10062-catalyzed hydration of 7 (1,5,6).  Typically, Cg10062 preparations used in these 
studies have a Km = 4.2 ± 0.3 mM and a kcat = 0.16 ± 0.01 s-1 using 7.  cis-CaaD  activity 
was measured by following the absorbance decrease at 224 nm (ε = 2900 M-1 cm-1), as 
described elsewhere (1).  Mass spectral analyses were carried out using the indicated 
instruments, which are housed in the Analytical Instrumentation Facility Core in the 















4.2.1 Transformation, Expression, and Purification for Cg10062 and Mutants 
Transformation of Expression Cells for Cg10062.  E. coli BL21-Gold(DE3) 
competent cells were thawed and stored on ice.  Competent cells (~100 µL) were pipetted 
into a pre-chilled 15-mL Falcon 2059 tube along with pCC5 (~50 ng) containing the 
Cg10062 gene (6). The reaction mixture was gently incubated on ice for 30 min.  During 
this time, a 900-µL aliquot of SOC medium was preheated in a water bath to 42 °C.  The 
reaction mixture was heat-pulsed for 20 s in a water bath at 42 °C and then incubated on 
ice for 2 min.  Subsequently, the 900-µL aliquot of SOC medium was added to the 
reaction mixture.  The cells were incubated at 37 °C for 1 h in an environmental shaker at 
225 rpm. The cells were then concentrated by centrifugation (500 rpm for 5 min), and a 
600-µL aliquot of the supernatant was removed.  The cells were resuspended in the 
remaining supernatant.  A portion of the resulting transformation reaction mixture (200 
µL) was plated, using a sterile spreader, onto an LB/Ap (50 µg/mL) agar plate.  The plate 
was then incubated overnight (~ 16 h) at 37 °C.   
Expression and Purification of Cg10062.  Wild-type Cg10062 was produced in E. 
coli BL21-Gold(DE3) cells using the T7 expression system.  The freshly transformed E. 
coli cells, with the plasmid coding the Cg10062 gene, were collected from a plate and 
used to inoculate three 2-liter flasks containing 1L of LB/Ap (100 mg/L).  After 
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overnight growth at 30 °C in an environmental shaker at 225 rpm, cells were harvested 
by centrifugation (15 min at 7,000 rpm) and stored at -20 °C until further use.  Typically 
1 L of culture yields 6 g of cells. 
Cells (18 g) were thawed and suspended in 10 mL of 10 mM Tris-SO4 buffer, pH 
8.0, and placed on ice.  Cells were disrupted, while stirring on ice, by sonication at 60 W 
output (using a W385 sonicator from Heat Systems-Ultrasonics, Inc.) for ten 2-min 
intervals using 5-s pulses with a cycle time of 50%.  After each 2-min interval, cells were 
allowed to sit for 5 min. DNase (10 µL of a 10 Units/µL solution) and RNase (10 mL of a 
500 µg/mL solution) were added to the solution and allowed to stir on ice for 1 h.  The 
lysed cells were then centrifuged at 17,000 rpm for 45 min. The supernatant was retained 
and centrifuged at 60,000 rpm for 1 h.  
 Subsequently, the supernatant was filtered through a 0.2 µm-pore diameter filter 
and applied to a TSKgel DEAE-5PW anion-exchange column (150 × 21.5 mm), which 
had been previously equilibrated with 10 mM Tris-SO4 buffer, pH 8.0.  The column was 
washed with 10 mM Tris-SO4 buffer, pH 8.0, containing 0.5 M Na2SO4 for 20 min.  The 
protein was eluted using a linear gradient (0-0.5 M Na2SO4) at a flow rate of 5 mL/min 
over a 90 min period.  Fractions were collected at 1.75 min intervals (8.75 mL).  
Fractions (#8-35) with the highest purity (as determined by SDS-PAGE) were pooled and 
concentrated to ~20 mL using an Amicon stirred cell equipped with a YM10 (10,000 
MW cutoff) ultrafiltration membrane and stored at 4 °C.  
Solid (NH4)2SO4 was added to the concentrate to make a final concentration of 
1.6 M.  After stirring for 1 h at 4 °C, the solution was centrifuged at 11,000 rpm for 15 
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min.  The supernatant was then passed through a 0.2 µm-pore diameter filter and applied 
to a TSKgel Phenyl-5PW column (150 × 21.5 mm) which had previously been 
equilibrated with 10 mM Tris-SO4 buffer, pH 8.0, containing 1.6 M (NH4)2SO4. The 
protein was eluted using a decreasing linear gradient [1.6-0 M (NH4)2SO4] at a flow rate 
of 5 mL/min.  Fractions were collected at 1.75 min intervals (8.75 mL) during the 90 min 
program.  Fractions (#19-24) with the highest purity (as determined by SDS-PAGE) were 
pooled and concentrated to ~10 mL by an Amicon stirred cell equipped with a YM10 
(10,000 MW cutoff) ultrafiltration membrane, and stored at 4 °C.  This purification 
resulted in ~200 mg of 95% pure protein as assessed by ESI mass spectroscopy and SDS-
PAGE.  The observed monomer mass for Cg10062 was 17,092 Da (calc. 17,092 Da).   
Expression and Purification of P1A-Cg10062.  The P1A mutant of the Cg10062 
gene was transformed and the gene product expressed in E. coli BL21-Gold(DE3) cells as 
described for wild-type. Typically, 1 L of culture yields 6 g of cells.  The cells (~12 g) 
were lysed and the enzyme purified following the protocol described for the wild-type 
enzyme. Fractions (#12-35) from the TSKgel DEAE-5PW anion-exchange column with 
the highest purity (as determined by SDS-PAGE) were pooled and concentrated to ~20 
mL using an Amicon stirred cell equipped with an YM10 (10,000 MW cutoff) 
ultrafiltration membrane.  Fractions (#20-22) from the TSKgel Phenyl-5PW column with 
the highest purity (as determined by SDS-PAGE) were pooled and concentrated to ~1.5 
mL using an Amicon stirred cell equipped with an YM10 (10,000 MW cutoff) 
ultrafiltration membrane and stored at 4 °C.  This purification resulted in ~7 mg of 95% 
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pure protein as assessed by ESI mass spectroscopy and SDS-PAGE. The observed 
monomer mass for P1A-Cg10062 was 17,067 Da (calc. 17,067 Da). 
Expression and Purification of R70A-Cg10062.  The R70A mutant of the 
Cg10062 gene was transformed and the gene product expressed in E. coli BL21-
Gold(DE3) cells as described for wild-type. Typically, 1 L of culture yields 6 g of cells.  
The cells (~6 g) were lysed and the enzyme purified following the protocol described for 
the wild-type enzyme. Fractions (#14-35) from the TSKgel DEAE-5PW anion-exchange 
column with the highest purity (as determined by SDS-PAGE) were pooled and 
concentrated to ~18 mL using an Amicon stirred cell equipped with an YM10 (10,000 
MW cutoff) ultrafiltration membrane.  The fraction (#26) from the TSKgel Phenyl-5PW 
column with the highest purity (as determined by SDS-PAGE) was concentrated to ~2 
mL using an Amicon stirred cell equipped with an YM10 (10,000 MW cutoff) 
ultrafiltration membrane and stored at 4 °C.  This purification resulted in ~35 mg of 95% 
pure protein as assessed by ESI mass spectroscopy and SDS-PAGE. The observed 
monomer mass for R70A-Cg10062 was 17,008 Da (calc. 17,008 Da). 
Expression and Purification of R73A-Cg10062.  The R73A mutant of the 
Cg10062 gene was transformed and the gene product expressed in E. coli BL21-
Gold(DE3) cells as described for wild-type. Typically, 1 L of culture yields 6 g of cells.  
The cells (~6 g) were lysed and the enzyme purified following the protocol described for 
the wild-type enzyme. Fractions (#14-35) from the TSKgel DEAE-5PW anion-exchange 
column with the highest purity (as determined by SDS-PAGE) were pooled and 
concentrated to ~18 mL using an Amicon stirred cell equipped with an YM10 (10,000 
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MW cutoff) ultrafiltration membrane.  The fraction (#24) from the TSKgel Phenyl-5PW 
column with the highest purity (as determined by SDS-PAGE) was concentrated to ~2 
mL using an Amicon stirred cell equipped with an YM10 (10,000 MW cutoff) 
ultrafiltration membrane and stored at 4 °C.  This purification resulted in ~43 mg of 95% 
pure protein as assessed by ESI mass spectroscopy and SDS-PAGE. The observed 
monomer mass for R73A-Cg10062 was 17,008 Da (calc. 17,008 Da). 
Expression and Purification of E114Q-Cg10062.  The E114Q mutant of the 
Cg10062 gene was transformed and the gene product expressed in E. coli BL21-
Gold(DE3) cells as described for wild-type. Typically, 1 L of culture yields 6 g of cells.  
The cells (~6 g) were lysed and the enzyme purified following the protocol described for 
the wild-type enzyme. Fractions (#14-35) from the TSKgel DEAE-5PW anion-exchange 
column with the highest purity (as determined by SDS-PAGE) were pooled and 
concentrated to ~18 mL using an Amicon stirred cell equipped with an YM10 (10,000 
MW cutoff) ultrafiltration membrane.  The fraction (#25) from the TSKgel Phenyl-5PW 
column with the highest purity (as determined by SDS-PAGE) was concentrated to ~2 
mL using an Amicon stirred cell equipped with an YM10 (10,000 MW cutoff) 
ultrafiltration membrane and stored at 4 °C.  This purification resulted in ~33 mg of 95% 
pure protein as assessed by ESI mass spectroscopy and SDS-PAGE. The observed 
monomer mass for E114Q-Cg10062 was 17,092 Da (calc. 17,092 Da). 
4.2.2 Inhibition and Protection Experiments of Cg10062 
  Irreversible Inhibition of Cg10062 by (R)- and (S)-6.  The time-dependent 
inactivation of Cg10062 by (R)- and (S)-6 was characterized using a previously described 
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protocol (8), with the following modifications.  Varying concentrations of (R)-6 (0.99-
33.0 mM) or (S)-6 (4.8-56.5 mM) were incubated with the enzyme in 20 mM Na2HPO4 
buffer (pH 9.0) at 22 °C.  The initial incubation mixtures (total volume of 110 µL) were 
made up in 1.5 mL eppendorf micro test tubes and contained 100 µM of Cg10062 (based 
on monomer concentration).  Aliquots (10 µL) from these mixtures were removed at 
various time intervals, diluted into 1 mL of 20 mM Na2HPO4 buffer (pH 9.0), and 
assayed for residual activity using 7.  Assays were initiated by the addition of 7 (4 µL 
from a 365 mM stock solution) to give a final concentration of 1.5 mM for 7 in all 
experiments.  Stock solutions of 7 were made up in 100 mM Na2HPO4 buffer (pH ~9) 
and the pH was slowly adjusted to 7.3 by the addition of 2 µL-aliquots of a 1 M NaOH 
solution.  Stocks solutions (100 mM) of (R)- or (S)-6 were made up in 100 mM NaH2PO4 
buffer (pH 7.3).  For experiments using the (R)-enantiomer, rates were monitored for 120 
s and for experiments using the (S)-enantiomer, rates were monitored for 200 s.  The 
initial time point (t = 0) corresponded to the rate measured for an aliquot removed before 
the addition of (R)- or (S)-6.  This activity was defined as 100% activity.  The addition of 
inhibitor [(R)-6 = 1-50 µL and (S)-6 = 5-130 µL] diluted the enzyme so that the final 
enzyme concentration ranged from 67-99 µM for the (R)-enantiomer and 44-95 µM for 
the (S)-enantiomer.  Hence, for each aliquot removed, the observed rate was divided by 
the enzyme concentration (in the assay mixture) and the resulting rate was divided by that 
obtained for the 100% activity.  The kobs values were plotted against the initial inhibitor 
concentrations, and the kinetic parameters (KI and kinact) were determined as described 
elsewhere (14, 15).  
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  Protection of Cg10062 from Inactivation by (R)- and (S)-6.  The incubation 
mixtures for the substrate protection studies were made up as described above and 
elsewhere (8), with the following modifications.  Accordingly, Cg10062 (100 µM based 
on monomer concentration) was incubated with varying concentrations of 7 (0-5.25 mM) 
in 20 mM NaH2PO4 buffer (pH 7.3) at 22 °C.  After a 30-s interval, a fixed concentration 
of (R)- or (S)-6 (0.4 mM or 4.0 mM, respectively) was added to the mixture.  Aliquots 
(10 µL) were removed at various time intervals, diluted into 1 mL of 20 mM Na2HPO4 
buffer (pH 9.0) and assayed for residual activity.   
  Irreversibility of Inactivation of Cg10062 by (R)- and (S)-6.  Three samples were 
made up containing ~1.5 mg of enzyme (80 µL of a 18.5 mg/mL solution) and a 
sufficient quantity of 20 mM Na2HPO4 buffer (pH 9.0) to give a final volume of 990 µL.  
Two samples were treated with (R)- or (S)-6 [10 µL from a 100 mM stock solution in 100 
mM NaH2PO4 buffer, pH 7.3] and a third one was treated with 100 mM NaH2PO4 buffer, 
pH 7.3 (10 µL).  After a 5-day incubation period at 4 °C, an aliquot (200-µL) was 
removed from the control and the (R)-6-modified Cg10062 sample and subjected to 
Sephadex G-25 chromatography as described (5).  Subsequently, a solution was made up 
from each set of fractions such that a final concentration of 2 µM enzyme (~520 µL of a 
0.26 mg/mL) was obtained in 3.5 mL of 20 mM Na2HPO4 buffer, pH 9.0.  A 1-mL 
aliquot was removed from each solution and assayed for activity using 7.  Activity assays 
were initiated by the addition of 7 (4 µL from a 365 mM stock solution made up as 
described above) to give 7 in a final concentration of 1.5 mM.  The remaining solution (~ 
2.5 mL) was stored at 4 °C and assayed after an additional 3-day incubation period.  The 
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sample containing Cg10062 and (S)-6 was incubated for 10 days at 4 °C, and then 
processed in a comparable manner.  
4.2.3 Irreversible Inactivation of cis-CaaD 
  Irreversible Inhibition of cis-CaaD by (R)-6.  The time-dependent inactivation of 
cis-CaaD by (R)-6 was determined using varying concentrations of inhibitor (0-14 mM) 
and enzyme (20 µM based on monomer concentration) in 20 mM Na2HPO4 buffer (pH 
9.0) at 22 °C, as described elsewhere (8).  The incubation mixtures (total volume of 101-
114 µL) were made up in 1.5 mL eppendorf micro test tubes.  Aliquots (10 µL) from 
these mixtures were removed at various time intervals, diluted into 1 mL of 20 mM 
Na2HPO4 buffer (pH 9.0), and assayed for residual activity using 2 in a final 
concentration of 200 µM.  The initial time point (t = 0) corresponded to the aliquot 
removed immediately after the addition of (R)-6 to the incubation mixture.  The cis-CaaD 
activity measured for this aliquot was defined as 100% activity.  Activity assays were 
initiated by the addition of an aliquot of 2 (4 µL) removed from a 50 mM stock solution 
made up in 100 mM Na2HPO4 buffer (pH 9.1).  The pH of the stock solution was 
adjusted ~7.5 by the addition of small quantities of 1 M NaOH.   
4.2.4 Mass Spectral Analysis of Cg10062 and Mutants 
  Mass Spectral Analysis of Cg10062 and Mutants Incubated with (R)- and (S)-6.  
The covalently modified Cg10062 samples were prepared for mass spectral analysis by 
the incubation of the enzyme with (R)- or (S)-6 in 20 mM Na2HPO4 buffer (pH 9.0) as 
follows.  Each sample contained ~1.5 mg of enzyme (~81 µL of a 18.5 mg/mL solution) 
and a sufficient quantity of 20 mM Na2HPO4 buffer (pH 9.0) to give a final volume of 
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990 µL.  The samples were treated with (R)- or (S)-6 [10 µL from a 100 mM stock 
solution of (R)- or (S)-6 in 100 mM NaH2PO4 buffer, pH 7.3].  A control sample was 
made up similarly, but the enzyme was treated with a 10-µL portion of buffer.  
Subsequently, the mixture containing Cg10062 and (R)-6 was incubated at 4 °C for 24 h 
and analyzed.  The control sample and the sample containing Cg10062 and (S)-6 were 
incubated at 4 °C for 10 days and aliquots removed and analyzed after 24 h, 48 h, 5 days, 
and 10 days.  The P1A, R70A, R73A, and E114Q mutants of Cg10062 were incubated 
separately with (R)- or (S)-6 in 20 mM Na2HPO4 buffer (pH 9.0) as follows.  Samples 
contained ~1.75 mg of enzyme (~100 µL of a 17.5 mg/mL solution) and a sufficient 
quantity of the 20 mM Na2HPO4 buffer to give a final volume of 495 µL.  The samples 
were treated with (R)- or (S)-6 [5 µL from a 100 mM stock solution of (R)- or (S)-6 in 
100 mM NaH2PO4 buffer, pH 7.3].  The mixtures were incubated at 4 °C for 10 days and 
aliquots removed and analyzed after 24 h, 5 days, and 10 days.  Samples for electrospray 
ionization mass spectrometry (ESI-MS) analysis were made up as described (5), and 
analyzed using an LCQ electrospray ion trap mass spectrometer (ThermoFinnigan, San 
Jose, CA).    
4.2.5 Peptide Mapping of Cg10062 
  Peptide Mapping of Cg10062 Inactivated by (R)- and (S)-6.  Three samples were 
made up containing ~1 mg of enzyme (39 µL of a 26.5 mg/mL solution) and a sufficient 
quantity of 20 mM NaH2PO4 buffer (pH 7.3) to give a final volume of 500 µL.  Two 
samples were treated with (R)- or (S)-6 [5 µL from a 100 mM stock solution in 100 mM 
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NaH2PO4 buffer, pH 7.3] and a third sample was treated with buffer (5 µL).  After a 24-h 
incubation period at 4 °C, the samples were subjected to Sephadex G-25 chromatography 
as described (5), yielding three sets of fractions containing modified Cg10062 [by (R)- or 
(S)-6] or unmodified Cg10062.  A sufficient quantity of protein was removed from the 
fraction containing the highest concentration of protein (now in 100 mM NH4HCO3 
buffer, pH 8.0) to give ~27 µg of enzyme, which was diluted into the necessary quantity 
of 100 mM NH4HCO3 buffer to yield a final volume of 45 µL.  After the addition of a 5-
µL aliquot of 10 M guanidine HCl, the three samples were incubated for 1 h at 37 °C.  
The protein samples were then incubated for an additional 48 h at 37 °C with sequencing 
grade protease V-8 (2 µL of a 10 mg/mL stock solution made up in water) (16).  
Subsequently, the V-8-treated samples were made up and analyzed on the delayed 
extraction Voyager-DE PRO matrix assisted laser desorption/ionization time-of-flight 
(MALDI-TOF) instrument (PerSeptive Biosystems, Framingham, MA) as described 
previously (5).  Selected ions in the samples were also subjected to MALDI-Post-Source 
Decay (PSD) analysis using the protocol described elsewhere (5, 17). 
4.2.6 Mass Spectral Analysis of cis-CaaD and MSAD 
  Mass Spectral Analysis of cis-CaaD Incubated with (S)-6 and MSAD Incubated 
with (R)- and (S)-6.  A sample of cis-CaaD was made up as described above for Cg10062 
and treated with (S)-6 [10 µL from a 100 mM stock solution in 100 mM NaH2PO4 buffer, 
pH 7.3].  Similarly, samples of MSAD were made up and treated with (R)- and (S)-6 [10 
µL from 100 mM stock solutions in 100 mM NaH2PO4 buffer, pH 7.3].  The samples 
were incubated at 4 °C for 10 days and aliquots removed and analyzed after 24 h, 5 days, 
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and 10 days as noted in the text.  The samples were prepared for mass spectral analysis as 
described elsewhere (5), and subjected to ESI-MS analysis.   
4.3  Results 
4.3.1 Inactivation and Protection Experiments of Cg10062 
  Time-dependent Inactivation of Cg10062 by (R)- and (S)-6.  Cg10062 is 
irreversibly inactivated by both (R)- and (S)-6 in a time-dependent first-order process 
(Figures 1A,B).  The kobs values from 18 experiments using (R)-6 and the kobs values from 
15 experiments using (S)-6 were plotted versus the initial inhibitor concentrations and fit 
to a rectangular hyperbola2.  The values of KI and kinact obtained from the plot for (R)-6 
(Figure 2A) were 14.0 ± 2.1 mM and 0.021 ± 0.001 s-1, respectively.  The values obtained 
from the plot for (S)-6 (Figure 2B) were 71.2 ± 12.7 mM and 0.005 ± 0.001 s-1, 
respectively.  Assuming KI is an estimate of binding affinity, these values indicate that 
(R)-6 binds more tightly (~5.1-fold) at the active site than the (S)-enantiomer and that at 





     





Figure 4.1.  Time-dependent inactivation of Cg10062 by (R)- and (S)-6.  (A) A 
logarithmic plot of the percent Cg10062 activity remaining as a function of time using 
varying amounts of (R)-6 (open triangles, 0.99 mM; filled triangles, 2.9 mM; open 
circles, 4.8 mM; filled circles, 6.5 mM; open rectangles, 9.1 mM; filled rectangles, 33.0 
mM).  (B) A logarithmic plot of the percent Cg10062 activity remaining as a function of 
time using varying amounts of (S)-6 (open triangles, 4.8 mM; filled triangles, 9.1 mM; 
open circles, 16.7 mM; filled circles, 23.1 mM; open rectangles, 37.5 mM; filled 
rectangles, 56.5 mM).  For purposes of clarity, the rates obtained for six experiments are 
shown.  The data from all of the experiments were used to calculate kobsd.   
  
  In order to compare directly the inactivation of Cg10062 with that of cis-CaaD, 
the kinetic parameters for the inactivation of cis-CaaD by (R)-6 were determined.  
Accordingly, the kobs values from 18 experiments using cis-CaaD and (R)-6 were fit to a 
rectangular hyperbola.  The values of KI and kinact obtained from the plot for (R)-6 (Figure 
2C) were 10.8 ± 1.6 mM and 0.20 ± 0.02 s-1, respectively3.  Although (R)-6 binds 
comparably to both enzymes (as indicated by the similar KI values), the (R)-enantiomer is 
approximately a 9.5-fold more potent inhibitor of cis-CaaD than it is of Cg10062.  As 
noted elsewhere, (S)-enantiomer does not inactivate cis-CaaD, but functions as a weak 










Figure 4.2.  Plot of kobsd values obtained for the inactivation of Cg10062 by (R)- and (S)-6 
and cis-CaaD by (R)-6 versus the concentrations of inactivator.  (A) The kobsd values for 
18 experiments using (R)-6 and Cg10062 vs the concentration of (R)-6.  (B) The kobsd 
values for 15 experiments using (S)-6 and Cg10062 vs the concentration of (S)-6.  (C) 
The kobsd values for 18 experiments using (R)-6 and cis-CaaD vs the concentration of (R)-
6.  The data from all of the experiments were used to calculate kinact and KI, which are 
reported in the text. 
 
  Both plots for the inactivation of Cg10062 show saturation kinetics, indicating 
that inactivation occurs by the prior formation of a dissociable complex between enzyme 
and inhibitor at the active site (18).  Further evidence for binding at the active site comes 
from substrate protection studies using 7, which at four different concentrations slows the 
inactivation of Cg10062 by (R)-6, and at two different concentrations slows the 









Figure 4.3.  Protection of Cg10062 from inactivation by (R)- and (S)-6 using substrate 7.  
(A) Cg10062 (100 µM) was incubated with four different concentrations of 7 (open 
triangles, 0 mM; filled triangles, 1.0 mM; open circles, 2.1 mM; filled circles, 3.5 mM; 
open rectangles, 5.2 mM) for 30 s before the addition of (R)-6 (0.4 mM).  (B) The same 
quantity of Cg10062 was incubated with two different concentrations of 7 (open 
triangles, 0 mM; filled triangles, 1.7 mM; open circles, 3.5 mM) for 30 s before the 
addition of (S)-6 (4.0 mM).    
 
  The irreversible nature of inactivation was demonstrated by the observation that 
Cg10062 inactivated by either (R)- and (S)-6 did not regain activity after gel filtration on 
a PD-10 Sephadex G-25 column.  After 5 days, Cg10062 incubated with (R)-6 had no 
residual activity (using 7) compared to a control.  Gel filtration and an additional 3-day 
incubation period at 4 °C did not result in recovery of activity.  Incubation of Cg10062 
with (S)-6 completely inactivated the enzyme after a 10-day interval.  Once again, gel 
filtration and an additional 3-day incubation period at 4 °C did not result in recovery of 
activity.  
4.3.2 Mass Spectral Analysis of Cg10062 
  Mass Spectral Analysis of Cg10062 Treated with (R)- and (S)-6.  Both the (R)- 
and (S)-6-inactivated Cg10062 were subjected to ESI-MS analysis and the spectra 
compared to that of wild type.  An 11:1 ratio of inhibitor to enzyme concentration (based 
on monomer molecular mass) was used.  For Cg10062 inactivated by the (R)-enantiomer, 
the spectrum acquired after a 24-h incubation period shows a major signal corresponding 
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to a mass of 17,190 ± 2 Da (data not shown).  A similar spectrum is obtained after a 48-h 
incubation period.  The signal corresponds to the mass of Cg10062 (17,092 ± 2 Da) 
modified by the covalent attachment of a species with a mass of 88 Da.  There is no 
residual signal for unmodified Cg10062 indicating ~100% modification.   
  For Cg10062 inactivated by the (S)-enantiomer, the spectrum acquired after a 24-
h incubation period shows signals corresponding to masses of 17,092 ± 2 Da and 17,190 
± 2 Da (data not shown).  The signal at 17,092 Da corresponds to that of Cg10062 and 
the signal at 17,190 Da corresponds to Cg10062 modified by the covalent attachment of 
the species with a mass of 88 Da.  The intensities of the signals suggest 15-30% 
modification (in two separate runs).  The same spectrum is obtained after a 48-h 
incubation period, where the intensities of the signals now suggest ~45% modification.  
After 5 days, the intensities of the signals suggest 60-70% modification.  After 10 days, 
the signal at 17,190 Da predominates.  The relative intensities of the signals suggest 
~90% modification.   
  For both (R)- and (S)-6-inactivated Cg10062, the increase in mass corresponds to 
the expected molecular mass of 6 as its ring-opened derivative (7,8).  The mass does not 
distinguish between the attachment of a 2- or 3-hydroxypropanoate species.  However, 
for both enantiomers, Cg10062 shows only a single site of modification.   
4.3.3 Mass Spectral Analysis of cis-CaaD and MSAD 
  Mass Spectral Analysis of cis-CaaD Treated with (S)-6 and MSAD Treated with 
(R)- and (S)-6.  In a previous report, covalent modification of cis-CaaD by (S)-6 was not 
detected for a sample analyzed after a 24-h incubation period (8).  In view of the lengthy 
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incubation times required for near complete covalent modification of Cg10062 by the (S)-
enantiomer, cis-CaaD was incubated with (S)-6 for 10 days at a ratio of 11 to 1 (inhibitor 
to enzyme).  The spectrum showed only a signal corresponding to the mass of 
unmodified cis-CaaD, confirming that cis-CaaD is not covalently modified by (S)-6.  The 
inactivation of MSAD by (R)- and (S)-6 was not previously examined.  At ratios of 7 to 1 
and 11 to 1 (inhibitor to enzyme), the spectra for MSAD samples incubated with (R)- or 
(S)-6 for a 10-day period show only signals at 14,107 ± 2 Da (data not shown).  This 
mass corresponds to the expected mass of the MSAD monomer (11), and indicates that 
MSAD is not covalently modified by either enantiomer of 6.   
4.3.4 Mass Spectral Analysis of Cg10062 Mutants 
  Mass Spectral Analysis of Cg10062 Mutants Treated with (R)- and (S)-6.  Four 
active site mutants of Cg10062 (P1A, R70A, R73A, and E114Q) were incubated in 
individual reaction mixtures with (R)- and (S)-6 for 10 days at 4 °C (6).  Mass spectral 
analysis of the reaction mixtures containing the P1A, R70A, and R73A mutants showed 
that each one produced signals (17,066, 17,007, and 17,006 ± 2 Da, respectively) 
corresponding to expected molecular masses of the unmodified mutants (6).  Thus, Pro-1, 
Arg-70, and Arg-73 are essential for covalent modification of Cg10062 by either (R)- or 
(S)-6.  Mass spectral analysis of the reaction mixture containing the E114Q mutant 
revealed a more complex situation.  Analysis of the mixture containing (R)-6 and the 
E114Q mutant (7 to 1 ratio) after 24 h, showed two signals corresponding to the masses 
of the unmodified enzyme (17,092 ± 2 Da) and modified enzyme (17,180 ± 2 Da).  The 
relative intensities suggested 40% covalent modification.  Using the same ratio of 
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inhibitor to enzyme, the wild type Cg10062 was completely modified by (R)-6 after 24 h.  
After 5 days, mass spectral analysis showed complete covalent modification of the 
E114Q mutant by (R)-6.  Analysis of the mixture containing (S)-6 and the E114Q mutant 
(7 to 1 ratio) at 24 hours showed only a mass corresponding to unmodified enzyme.  
After 5 days, a second signal appeared corresponding to the mass of the modified 
enzyme.  The relative intensities of the signals indicated 20% modification.  After 10 
days, mass spectral analysis suggested 45% covalent modification of the E114Q mutant 
by the (S)-enantiomer.  Using the same ratio of inhibitor to enzyme, the wild type 
Cg10062 was 60% modified by (S)-6 after 10 days.  Thus, in contrast to cis-CaaD, where 
Glu-114 is not required for the inactivation reaction, it plays a role in the alkylation of 
Cg10062 by (R)- and (S)-6, as replacing it with a glutamine slows the inactivation 
reaction.    
4.3.5 Peptide Mapping of Cg10062 
  Identification of Pro-1 as the Site of Modification by (R)- and (S)-6.  ESI-MS 
analysis of incubation mixtures containing Cg10062 and (R)- or (S)-6 showed covalent 
attachment of a species with a mass of 88 Da to the enzyme.  The mass is consistent with 
modification of the enzyme by a 2- or 3-hydroxypropanoate species (7,8).  The modified 
residue was identified by incubating the three samples (unmodified Cg10062, (R)-6-
modified Cg10062, and (S)-6-modified Cg10062) with endoproteinase Glu-C (protease 
V-8) and analyzing the resulting peptide mixtures by MALDI-MS.  Although protease V-
8 cleaves peptide bonds at the carboxylate side of glutamate and aspartate residues, 
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(leaving Glu or Asp as the C-terminal residue), glutamates are preferred (in 100 mM 
ammonium bicarbonate buffer at pH 8.0) (16).   
  Mass spectral analysis identified five major peptide species in all three samples 
corresponding to peptide bond cleavage at Glu-15, Glu-30, Glu-41, Glu-60, Glu-75, Glu-
80, Glu-88, Glu-114, and Glu-126 (Table 1).  Additional peptide species were identified 
in the (R)- and (S)-6-modified Cg10062 samples having masses of 1983.86 Da and 
1983.74 Da, respectively.  The mass corresponds to the Pro-1 to Glu-15 peptide fragment 
covalently modified by 6.  The other four peptide fragments (Table 1) had not been 
modified.   
  The unmodified (1895.69 Da) and (R)- and (S)-6-modified fragments (1983.86 
and 1983.74 Da, respectively) were subjected to MALDI-PSD analysis in order to locate 
the residue with the covalently attached species (17).  The PSD spectrum of the 
unmodified peptide showed N-terminal sequence specific fragment ions b2 (199) and b3 
(362).  The PSD spectrum of the modified peptide showed modified fragment ions b2 
(287), corresponding to a modified Pro-1-Thr-2 fragment, and b4 (551), corresponding to 
the modified Pro-1 to Thr-4 fragment.  These observations narrowed the site of covalent 
attachment to Pro-1 or Thr-2.  Although the PSD spectra of the unmodified and two 
modified fragments did not show a b1 ion, corresponding respectively to Pro-1 or 
modified Pro-1, a proline immonium ion (70) and a modified proline immonium ion 
(158) were present in the spectra for the (R)- and (S)-6-modified fragments.  Hence, Pro-1 




Table 1.  Peptides Identified in the Protease V-8 digestion mixture of unmodified, and 
















1P – 15E 
31L – 41E 
61N – 75E 
81L – 88E 


























aThe monoisotopic singly charged masses are predicted from analysis of the translated 
amino acid sequence of the Cg10062 gene (corresponding to Cg10062) (6).  bThe 




4.4  Discussion 
  cis-CaaD and CaaD are isomer-specific dehalogenases grouped into different 
families in the tautomerase superfamily (1).  Tautomerase superfamily members have a 
signature β−α−β building block and a catalytic Pro-1 (19-21).  cis-CaaD and CaaD have 
different quaternary structures (trimer and hetereohexamer, respectively) and somewhat 
different catalytic mechanisms (1,5,7).  Cg10062 is a cis-CaaD family member that has 
CaaD activity, presumably due to a less stringent substrate specificity (6).  The 
quaternary structure of Cg10062 is identical to that of cis-CaaD and the mechanism is 
likely to be similar.  However, Cg10062 processes both isomers (i.e., 3 and 2) and is 
inactivated by both enantiomers of 6.  An understanding of the relaxed specificity of 
Cg10062 is expected to provide insights into the elements of substrate specificity for cis-
CaaD and CaaD and suggest how isomeric specificity of these two enzymes diverged.   
  (R)-oxriane-2-carboxylate (6) was previously characterized as a stereospecific 
affinity label of cis-CaaD (8).  Mass spectral and crystallographic analysis established 
that inactivation resulted from covalent modification of the Pro-1 nitrogen by (R)-2-
hydroxypropanoate at the C-3 position (7,8).  Pro-1, Arg-70, and Arg-73 were identified 
as essential active site residues for the inactivation mechanism (8).  The crystallographic 
analysis of the inactivated cis-CaaD implicated His-28 in the mechanism and suggested 
roles for Arg-70 and Arg-73 (7).  On the basis of these observations, it was proposed that 
Arg-73 and His-28 interact with the carboxylate group and position (R)-6 for covalent 
modification of Pro-1 (Scheme 2A).  The side chain of Arg-70 or an Arg-70-bound water 
molecule functions as the proton donor for the epoxide ring-opening reaction.  This 
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proposed orientation places the (R)-enantiomer in position for the alkylation reaction.  If 
the (S)-enantiomer binds similarly, the epoxide ring is flipped such that the Pro-1 





























  The presence of His-28 in cis-CaaD may be a critical factor in the enzyme’s 
vulnerability to alkylation (7).  CaaD, which is not inactivated by either enantiomer, lacks 
this residue or an equivalent.  Similar to the proposed binding mode for 3, the carboxylate 
group of 6 may interact with the two arginines (αArg-8 and αArg-11) in the active site of 
CaaD, thereby preventing one of the arginines from serving as a necessary proton source 
to facilitate ring opening.  We have also found that MSAD is not inactivated by either 
enantiomer of 6.  Like CaaD, MSAD has two arginines residues (Arg-73 and Arg-75), 
but lacks His-28 or an equivalent.  The two arginine residues of MSAD are proposed to 
interact with the substrate, and may likewise interact with the carboxylate group of 6 and 
prevent one from functioning as a proton source.  Evidently, there is not an alternate 
nearby proton source.    
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  Oxirane-containing compounds have been used extensively as affinity labels of 
enzymes and the subsequent characterization of the inactivated enzyme has provided 
considerable mechanistic insight (22-24).  Ring opening, with the concomitant alkylation 
and inactivation, generally involves acid/base catalysis and proceeds by one of two 
mechanisms (25).  In one mechanism, the acid catalyst protonates the oxygen of the 
oxirane ring (25).  Ring-opening produces a carbocation, which captures a nearby base 
catalyst at the more highly substituted carbon (25).  In a second mechanism, the base 
catalyst attacks the less sterically hindered carbon of the oxirane in conjugation with 
polarization of the carbon-oxygen ring by the acid catalyst.  The regiochemistry of the 
ring-opened product generated in the cis-CaaD reaction with (R)-6 would suggest that the 
second mechanism is operative.  However, it is unknown whether active site constraints 
affect the observed outcome (23). 
  The two key findings in this study are that both (R)- and (S)-6 inactivate Cg10062 
and that Glu-114 is an additional participant in the inactivation mechanism.  Otherwise, 
the inactivation process parallels that observed for cis-CaaD, and for the (R)-enantiomer, 
a similar mechanism can be envisioned.  Accordingly, the carboxylate group would 
interact with His-28 and Arg-73, and the side chain of Arg-70 or an Arg-70-bound water 
molecule would interact with the oxirane oxygen to facilitate ring opening.  Pro-1 is 
positioned to attack at C-3.  The lower potency [compared to cis-CaaD and (R)-6] 
suggests weaker binding and less favorable interactions with the key active site groups, 
and may reflect some “wobble” in the active site with regard to inhibitor positioning and 
binding.  Glu-114 might further position the epoxide for alkylation or maintain the 
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position of one of the essential residues such that replacement with a glutamine slows the 
inactivation process.   
  There are at least two possible mechanistic explanations (along with variations) 
for the inactivation of Cg10062 by the (S)-enantiomer.  If it is assumed that the 
carboxylate group of (S)-6 interacts with His-28 and Arg-73, one potentially interesting 
scenario involves a change in the regiochemistry of ring opening such that C-2 is the site 
of attachment.  This scenario could involve another unknown residue functioning as the 
proton source for the oxirane oxygen.  In a second scenario, the epoxide could bind in the 
active site of Cg10062 in a different orientation where the carboxylate group interacts 
with Arg-70 and Arg-73.  Ring opening could occur at C-2 or C-3 and His-28 could 
function as a proton source.  In both scenarios, the side chain of Glu-114 could favor a 
productive binding mode (i.e., one that results in alkylation) over a non-productive one.   
  In the proposed mechanism for Cg10062, Pro-1 functions as a general acid 
catalyst (6), raising the question of how the charged prolyl nitrogen is alkylated.  The 
similarity between the cis-CaaD and Cg10062 active sites suggests that the pKa values for 
the prolyl nitrogens will be comparable (~9.3) (1,8).  At the pH of the inactivation 
experiments (pH = 9.0), approximately 33% of the enzyme is in a protonation state where 
the prolyl nitrogen can function as a nucleophile.  Alkylation of the nitrogen perturbs the 
equilibrium and places an additional amount of enzyme into the nucleophilic and reactive 
form.  In this manner, the enzyme can become entirely alkylated.   
  The crystallographic analysis of cis-CaaD inactivated by (R)-6 uncovered the 
structural basis for stereospecific inactivation and suggested a mechanism (7).  In 
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addition, a comparison of the structure with that of CaaD (inactivated by 3-
bromopropiolate) (26) identified two potential determinants of the substrate specificities.  
First, the carboxylate groups of the isomeric substrates may interact at slightly different 
angles with the two active site arginines (αArg-8, αArg-11) of CaaD or the 
arginine/histidine cluster (Arg-70, Arg-73, His-28) of cis-CaaD such that the substrates 
are projected into different regions of the enzyme (7,26).  In cis-CaaD, the substrate is 
projected towards the surface (7), and in CaaD, the substrate is projected deeper into the 
enzyme (26).  In addition, the active site pockets fit the shapes of the respective 
substrates with Tyr-103 playing a role in blocking the binding of a trans-substrate in cis-
CaaD.  Because Cg10062 and cis-CaaD share these isomer discriminating residues, our 
understanding of the factors governing specificity is clearly incomplete.  A comparative 
analysis of the three structures will shed further light on the role of these groups in the 
individual specificities and how subtle changes relax the specificity.  Crystal structures of 
Cg10062 inactivated by the enantiomers of 6 are currently being pursued.   
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4.7  Footnotes 
 
1Abbreviations:  cis-CaaD and CaaD; cis- and trans-3-chloroacrylic acid dehalogenase, 
respectively; ESI-MS, electrospray ionization mass spectrometry; MALDI-PSD, matrix 
assisted laser desorption-ionization post-source decay; MALDI-TOF, matrix assisted 
laser desorption-ionization time-of-flight; MSAD, malonate semialdehyde decarboxylase; 
SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
 
2A better fit of the data can be obtained using the Hill equation, as found in the Grafit 
program (data not shown).  The resulting fit suggests positive cooperativity and may 
indicate that the inactivation of one subunit accelerates the rate of inactivation for the two 
remaining subunits.  Positive (or negative) cooperativity has not been detected for 
Cg10062 or cis-CaaD by steady state kinetics.   
 
3In a previous report (8), the concentrations of 6 were calculated based on a molecular 
weight of 88 Da, which corresponds to the free acid.  Hence, the actual concentrations are 
lower than the reported concentrations (8).  The concentrations in this report take into 
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